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Zusammenfassung
Morbus Alzheimer ist die ha¨ufigste Form der Demenzerkrankung, die 47 Millionen
Menschen weltweit betrifft. Zuku¨nftig steigende Zahlen sind vorhergesagt, da die
steigende Lebenserwartung das Risiko erho¨ht, an Morbus Alzheimer zu erkanken. So
stellt die Krankheit eine enorme Belastung fu¨r unsere Gesellschaft dar. Eine Heilung
wurde bisher noch nicht gefunden, trotz jahrzehntelanger Forschung.
Ein Kennzeichen der Erkrankung ist die Akkumulation vom β-Amyloid (Aβ),
welches als molekulare Erkla¨rung fu¨r die Krankheit gilt und deshalb Gegenstand in-
tensiver Studien ist. Aktuelle therapeutische Strategien zielen auf die Symptome der
Erkrankung und erste mechanistische Ansa¨tze, die in die Aβ-Produktion eingreifen,
blieben jedoch bisher erfolglos. Daher bleibt es u¨beraus wichtig, die Grundlagenbi-
ologie zu verstehen, die Morbus Alzheimer zugrunde liegt, um erfolgreiche Therapien
zu entwickeln. Obwohl Aβ ein Spaltprodukt des β-Amyloid-Vorla¨uferprotein (APP)
ist, ist die Funktion von APP weniger gut verstanden und bisherige Untersuchungen
begrenzen sich hauptsa¨chlich auf Neurone.
Der neuronale Informationsfluss zwischen Pra¨- und Postsynapsen ist stark von
angrenzenden Astrozyten abha¨ngig, die in synaptischer Plastizita¨t, Informationsver-
arbeitung und -u¨bertragung involviert sind. Die synaptische Plastizita¨t gilt als Mech-
anismus fu¨r Lernen und Geda¨chtnis. Die vorliegende Arbeit untersucht die physiol-
ogische Funktion von APP im Rahmen neuronaler synaptischer Plastizita¨t und den
damit assoziierten Astrozyten. Hierfu¨r wurden Modelle mit konstitutivem und kondi-
tionellem APP knock-out verwendet.
Im ersten Teil der Arbeit wird die Rolle von APP in struktureller und funktioneller
synaptischer Plastizita¨t im Hippokampus und Kortex beschrieben. Dabei zeigt sich,
dass die Dichte und Morphologie postsynaptischer Spines im Kortex weniger Plastizita¨t
aufweist, wenn APP in Neuronen und Astrozyten fehlt. Diese Plastizita¨tsdefizite
bleiben ohne Vera¨nderung der exzitatorischen Rezeptordichte. Selektives Ausschal-
ten von APP in Astrozyten fu¨hrt zu verminderter Anzahl plastischer Spines im Kor-
tex, wohingegen die Dichte der stabilen Spines im Hippokampus zunimmt. Außerdem
fu¨hrt das Fehlen von APP zu Defiziten der funktionellen Plastizita¨t, die sich durch
verminderte Signalversta¨rkung a¨ußert. Diese funktionelle Plastizita¨t wird vom Glio-
transmitter D-Serin potenziert, der von Astrozyten ausgeschu¨ttet wird. Da APP-KO
Tiere reduzierte D-Serin Werte im extrazellula¨ren Raum aufweisen, wurde die funk-
tionelle synaptische Plastizita¨t unter Zugabe von D-Serin untersucht.
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Zusammenfassung
Der zweite Teil der Arbeit befasst sich mit der Rolle von APP in Astrozyten, unter
dem Aspekt, dass diese aktiv bei der synaptischen Aktivita¨t beteiligt sind. Ca2+
ist ein essentielles Signalmoleku¨l, das viele zellula¨re Prozesse reguliert; so auch die
Gliotransmission. Hier wird gezeigt, dass APP eine wichtige Rolle in spontanen as-
trozyta¨ren Ca2+-Stro¨men in den vera¨stelten Kontaktbereichen zu Synapsen im Kortex
und Hippokampus spielt. Die Ca2+-Stro¨me in diesen perisynaptischen Strukturen wer-
den durch Mitochondrien reguliert, die in APP-KO Astrozyten morphologische und
funktionale Abweichungen aufweisen.
Zusammenfassend beschreiben die Ergebnisse dieser Arbeit eine physiologische
Rolle von APP in synaptischer Plastizita¨t und der damit zusammenha¨ngenen Funk-
tion von Astrozyten. Die Erkenntnisse sind wichtig fu¨r ein verbessertes Versta¨ndnis
von Morbus Alzheimer und fu¨r die Entwicklung neuer therapeutischer Strategien.
xvi
Summary
Alzheimer’s disease (AD) is the most common form of dementia affecting 47 million
people worldwide and rising numbers are predicted for the future, as increasing life
expectancy denotes increased risk of developing AD. The disease constitutes an enor-
mous burden for our society. Despite numerous therapeutical approaches, a cure for
AD has not been found yet.
One hallmark of AD is the accumulation of amyloid β (Aβ) which is intensively
studied and widely considered as molecular explanation for the synaptic pathology
in AD. Today’s therapeutic strategies target AD symptoms and first mechanistic
approaches, including interference with Aβ production, are failing in clinical trials.
Hence, it remains of utmost importance to further understand the fundamental biol-
ogy of AD-related physiology in order to develop successful therapeutic strategies. Aβ
is a cleavage product of the amyloid precursor protein (APP). However, the physio-
logical functions of APP remain less well understood and previous investigations have
been mainly confined to neurons.
Neuronal information flow between pre- and postsynapse is strongly dependent on
the adjacent astrocytes that are involved in synaptic information processing, transmis-
sion and plasticity. Synaptic plasticity is considered to be the underlying mechanisms
of learning and memory. In the present work, the physiological role of APP was in-
vestigated both in synaptic plasticity and associated astrocytes in a constitutive and
conditional knock-out model of APP (APP-KO).
In the first part of this work, the role of APP in structural and functional synaptic
plasticity is characterised in the cortex and hippocampus. The density and morphology
of postsynaptic compartments -the dendritic spines- display reduced plasticity when
APP is lacking in both neurons and astrocytes of the cortex. The reduced plasticity
does not involve excitatory receptor composition. Selective KO of APP in adjacent
astrocytes results in decreased plastic spines in the cortex, while increased spine num-
ber and more stable spines are observed in the hippocampus. Additionally, APP-KO
mice display functional plasticity deficits in the hippocampus manifested by reduced
synaptic signalling strength. The gliotransmitter D-serine is released by astrocytes
and potentiates functional plasticity in neurons. As extracellular levels of D-serine
are reduced in APP-KO animals, application of D-serine was tested for rescue of the
functional plasticity deficits.
The second part of this work focuses on the role of APP in astrocytes as active
xvii
Summary
partners in synaptic activity. Spontaneous Ca2+ activity, that is responsible for numer-
ous cellular processes and gliotransmission, was investigated in the astrocytic contact
sites to synapses. Ca2+ transients are shown to be reduced in the perisynaptic sites of
APP-KO astrocytes in the cortex and hippocampus. The Ca2+ activity is regulated by
mitochondria that are dysfunctional in APP-KO astrocytes evidenced by fragmented
morphology and prolonged Ca2+ uptake and release duration.
In summary, these findings ascribe a physiological role to APP in synaptic plasticity
and in associated astrocytic function. These insights are crucial for understanding the
biology of AD and for developing new therapeutic strategies.
xviii
Chapter 1
Introduction
1
1. Introduction
1.1 Morbus Alzheimer
1.1.1 History and epidemiology
In 1906, the German psychiatrist Alois Alzheimer described a special and until then
unknown case of his patient Auguste Deter. He reported temporal and spatial disori-
entation and tremendous memory deficiencies. Moreover, he observed a severe atrophy
in the brain after her death by the age of 55. The brain also displayed peculiar spots of
accumulations and strongly stained neurofibrils which he correlated to her dementia.
Today, these abnormalities are entitled amyloid plaques and neurofibrillar tangles and
constitute the hallmarks of Alzheimer’s disease (AD)(Figure 1.1)[1].
The term dementia is derived from the latin language and can be translated as
”out of mind”. It is descriptive for any kind of disease that includes loss of memory,
thinking, orientation, comprehension, calculation, speech, ability to learn and judge
[2].
Alzheimer’s disease is ascribed to two-thirds of all dementia cases. The growing
population and increasing life expectancy is a challenge of the today’s world [3]: Today,
47 million people worldwide live with dementia and 131.5 million are predicted for
2050 [4]. The current estimated worldwide costs of dementia are 818 billion US dollar.
However, many people with dementia have not received a diagnosis and therefore lack
care and treatment [4]. This current and increasing burden for the world’s society
is an emotional, social, political and financial challenge. Therefore, it is of utmost
importance to understand the disaese and develop appropriate therapeutic strategies.
1.1.2 Clinical symptoms
AD is a neurodegenerative disease that is characterised by progressive dementia from
a mild, moderate to severe stage [5]: Usually, about a decade passes by before the
illness becomes severe and patients die as a tragic consequence [6]. Loss of neurons in
the entorhinal cortex have been already detected during mild cognitive impairment [7]
suggesting that some parts of the brain are earlier and more affected than others [6].
Reduced cortical thickness can be monitored via magnetic resonance imaging (MRI)
in the living AD patients and correlated with cognitive decline [8].
There is evidence that AD does not simply cause neuronal loss resulting in si-
lencing of neuronal networks, but rather altered network activity that might actively
interfere with the complex processes underlying cognitive functions such as learning
and memory [6]. For instance, AD patients display hyperperactivation of the neuronal
network in the hippocampus during memory tasks [9]. This hyperactivity correlates
with decreased hippocampal volume and cortical thinning in AD-related brain regions
[10]. In brains of AD patients epileptic seizures can arise, which is most evident in
patients with mild forms of the disease [11].
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A B C
D
Figure 1.1. Histopathological hallmarks of the first Alzheimer patient Auguste Deter. (A)
Histological brain slice preparation of Auguste Deter by courtesy of Prof. Dr. Dr. h. c. Hans
Kretzschmar from the Institute for Neuropathology of the Ludwig-Maximilians-University Munich.
(B-D) Microscopic images taken and thankfully provided by Dr. Dr. Mario Dorostkar. (B)
Overview of Bielschowsky silver staining method for illustration of the AD hallmarks. Magnification
of a Aβ plaque (C) and neurofibrillary tangles (D).
1.1.3 Neuropathological hallmarks
Cortical thinning due to neuronal loss is one hallmark of AD and the atrophy can be
detected before the onset of dementia [12]. Two major hallmarks of AD are amyloid-β
(Aβ) plaques in the parenchyma and neurofibrillary tangles inside neurons (Figure
1.1). These deposits are associated with initiation of inflammatory processes involving
microglia and astrocytes [13],[14]. Usually, the earliest neuritic plaques, neurofibrillary
tangles, and neuropil threads appear in structures of the medial temporal lobe and
expand in limbic and isocortical areas [15]. This has critical consequences on episodic
memory function explaining the deficits in learning and memory in AD.
Neurofibrillary tangles are inclusions in neurons consisting of aggregated tau pro-
tein [16]. Tau is a microtubuli associated protein that stabilises microtubuli and is
thereby important for transport of molecules along axons, axonal outgrowth, and cell
polarity [17]. Hyperphosphorylation of tau leads to dissociation of tau from micro-
tubuli resulting in destabilisation of those [18]. The hyperphosphorylation of tau also
favours its accumulation in β-sheet configuration which forms neurofibrillary tangles
and dystrophic neurites, as tau accumulates in somatodendritic compartments instead
of functioning in axons.
The formation of distinct plaques consisting of accumulated Aβ [19] is another
hallmark of AD. Aβ accumulation is an intensively studied hallmark in AD and will
be further described in the context of the amyloid cascade hypothesis. However, the
3
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level of cognitive impairment correlates with the burden of neocortical neurofibrillary
tangles [20].
The entailed atrophy visible through decreased brain volume and weight results
from shrinkage and loss of neuronal processes, synapses and neurons [6]. Much evi-
dence suggests that synapses and dendrites are predominantly affected by AD. Loss
of neuronal connections can better explain cognitive decline in AD than neuronal loss
[21].
Brain tissue samples from brains of AD patients and animal models of AD dis-
played alterations in levels of proteins and genes directly involved in neuronal Ca2+
signalling suggesting a perturbed Ca2+ homeostasis with detrimental consequences
such as excitotoxicity and apoptosis [22]. Importantly, memory deficits in AD pa-
tients correlate best with synapse loss rather than Aβ plaque burden or neurofibrillary
tangles [23].
1.1.4 Risk factors
AD is probably caused by obscure interplay among numerous genetic, epigenetic and
environmental factors [6]. A genereal risk factor of AD is increasing age, as from the
age of 65 the probability to develop AD doubles [24].
In inherited familiar cases of AD autosomal dominant mutations in amyloid pre-
cursor protein gene (APP), presenilin PSEN1, and PSEN2 lead to familial early-onset
AD (<60 years) while APOE isoforms (the APOE4 allele) [25] and TREM2 variants
[26] are known as the most important risk factors for sporadic late-onset AD. The
mutations in APP and PSEN (encodes the catalytic center of γ-secretase) impact
APP processing resulting in increased production of aggregation prone Aβ peptides
[25]. Moreover, overexpression of APP alone leads to Aβ accumulation. Consequently,
patients with Down Syndrome (trisomy 21) harbouring a third copy of APP, due to
the presence of APP on chromosome 21, show evidences of AD at early age [27],[19],
[28].
A healthy life style has protective effects against dementia [29], while a history of
stroke increases the risk of dementia in the older population [30].
There is currently no treatment to cure dementia or alter the disease progression
(World Health Organisation, WHO 2018)[31]. The WHO recognises dementia as a
’public health priority’. In a ’Global action plan on the public health’ the organisation
responses to dementia for the years 2017-2025. However, there are numerous ongoing
treatment approaches in different stages of clinical trials that target, among others,
proteolytic cleavage of the amyloid precursor protein (APP) (e.g. BACE1 inhibition)
or Aβ accumulation (antibody therapy) [32].
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1.2 The amyloid cascade hypothesis
The amyloid cascade hypothesis postulates that accumulation and deposition of Aβ is
the driving factor of the pathological courses of AD [33],[34],[35].
Later, the hypothesis was refined by stating that gradual changes in the levels and
conformation of Aβ in the brain are thought to initiate the amyloid cascade. Thus, due
to an imbalance of Aβ production and clearance, Aβ forms soluble oligomers which
are delineated to be the toxic structures that cause synaptic dysfunction. Further
formation of insoluble amyloid plaques results in an immun response that involves
activation of microglia and astrocytes. Subsequently, microtubule associated protein
tau gets hyperphosphorylated and oligomerises forming insoluble aggregates. Further
progression of the disease results in dysfunction and loss of neurons. The final hallmark
of the disease is the tangle and plaque pathology (Figure 1.2)[36].
The combination of pathology and genetics in humans constitute the pillars of
the hypothesis ascribing the primary role in the etiology of AD to Aβ. Basis for the
hypothesis was provided by sequencing of the amino acid sequence of Aβ as the main
component of the pathological hallmark plaque [19] and cerebral angiopathies [37]
from brains of AD patients. Since neuropathological hallmarks of AD were found in
Down syndrome patients and the protein sequence resembled the one from sporadic
AD patients [38],[39], the APP gene was cloned and localised on chromosome 21
shortly after [40],[41]. Due to a third copy of chromosome 21 in Down Syndrome
patients, Aβ production is increased which leads to Aβ deposition and dementia at
an early age. The identification of a mutation in the APP gene in early-onset AD
patients that is pathologically identical to sporadic, late-onset AD, was an important
step in understanding the disease cause [42]. Missense mutations in PSEN genes were
identitified responsible for early-onset AD [43],[25]. They are catalytic components
of γ-secretases a cleaving enzyme of APP [44]. Nowadays, hundreds of mutations in
PSEN1 and PSEN2 and APP are identified that can cause early-onset familial AD
[45]. With regard to sporadic late-onset AD, isoforms of APOE4 gene increase the risk
for spontaneous AD by interfering with the clearance of Aβ [46],[47],[25]. Furthermore,
a coding mutation (A673T) in the APP gene was discovered that protects against AD
and cognitive decline in the elderly without AD [48],[49].
Physiological production [51] and clearance of Aβ [52] and synapse change as-
sociated with soluble Aβ in AD brains [53] led to revision of the amyloid cascade
hypothesis suggesting Aβ oligomers as toxic component in the development of AD
[50],[36]. As Aβ is the initiating cause of AD, the hypothesis implies that inhibition
of excessive production and removal of toxic Aβ would prevent or cure the disease.
The early recognition of the disease needs to be advanced [54] so that the therapy can
start with the first changes in Aβ levels 25 years before expected symptom onset [55].
Despite many approaches targeting Aβ levels to improve symptomes, there is no
cure of the disease yet [56],[57] and clinical studies targeting Aβ have been failing [32].
Hence, the amyloid hypothesis is under debate and alternative approaches are taken
into consideration [58].
5
1. Introduction
Figure 1.2. The amyloid cascade hypothesis. The course of Alzheimer’s disease according to
the amyloid cascade hypothesis. Illustration adapted from Hardy et al. [50] and Haass et al. [36].
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1.3 The amyloid precursor protein (APP)
The amyloid precursor protein (APP) is a type I transmembrane protein that plays
a crucial role in the pathogenesis of AD. It belongs to a small gene family further
including the amyloid precursor-like proteins APLP1 [59] and APLP2 [60] in mammals
[61],[62].
All three family members share conserved extracellular domains E1 (growth-factor
like domain (GFLD), copper-binding domain (CuBD)) and E2 and acidic domain
[63],[64]. Additionally, the Kunitz-type protease inhibitor domain (KPI) is harboured
by isoforms of APP and APLP2 (Figure 1.3)[60],[63]. Processing by several secre-
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Figure 1.3. The structure of APP family members. The amyloid precursor protein (APP)
and the family members amyloid precursor-like proteins 2 and 1 (APLP2 and APLP1). All APP
family members harbour a conserved extracellular domain 1 (E1) consisting of a heparin-binding
domain (HBD1) and a copper-binding domain (CuBD), a conserved E2 domain and an acidic
domain. Isoforms of APP and APLP2 contain a Kunitz-type protease inhibitor domain (KPI). APP
exclusively contains the Aβ peptide. The short intracellular domain carrying the YENPTY motif is
present in all APP family members (AICD: APP intracellular domain, ALID2: APP-like intracellular
domain 2, ALID1: APP-like intracellular domain 1).
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tases results in various extra- and intracellular APP fragments [65]. The intracellular
YENPTY motif differs among all three family members: APP contains the APP in-
tracellular domain (AICD), APLP2 the APP-like intracellular domain 2 (ALID2), and
APLP1 the APP-like intracellular domain 1 (ALID1) [63]. APP family members in-
teract with multiple proteins via their extracellular and intracellular domains [63],[64].
Even though the family members differ in their constitution, α-, β- and γ-secretases
process them in a similar way. Importantly, proteolytic processing of only APP releases
the AD-related Aβ peptide [65].
1.3.1 Localisation and proteolytic cleavage
APP is a ubiquitous protein that is expressed in systemic organs and in the brain in
different cell types [66],[67]. APP localises at the plasma membrane of various cell or-
ganelles, such as endoplasmic reticulum (ER), Golgi apparatus [68], and mitochondria
[69],[70].
In the brain, the relative abundance of the different APP isoforms are distributed in
a cell- and region-specific manner. There are three different isoforms APP770 /APP751
/APP695 whose mRNAs appear in a ratio of approximately 1:10:20 in the cerebral
cortex [71]. Isoforms APP770 and APP751 have been shown to be more abundant
in certain brain areas of AD patients [71]. APP is also expressed in astrocytes and
microglia [72]. For instance, the mRNAs of KPI containing isoforms APP770/751 were
found to be elevated in astrocytes in comparison to neurons [73].
In neurons, APP is decribed to be synthesised and localised in synaptosomes and
growth cones [74], postsynaptic density [75], and is transported along axons [66] and
dendrites.
APP undergoes post-translational modifications in the Golgi apparatus including
glycosylation, sulphation, phosphorylation and palmitoylation [76],[77]. Posttransla-
tional modifications are taking place during the secretory pathway, when APP passes
from the ER to the plasma membrane. This is also the major compartment, where
APP undergoes proteolytic prossessing [78]. Only a fraction of the expressed full-length
APP resides the plasma membrane while about 90% stays in the Golgi network. If
APP is not shed at the plasma mebrane, the YENPTY internalisation motif is present
which triggers endocytosis [79]. Subsequently, APP is transported to endosomes and
is partly recycled to the plasma membrane or degraded in lysosomes [80].
In principle, there are two proteolytic processing pathways in which APP in cleaved
by different secretases: In the amyloidogenic pathway β- and γ-secretases processesing
of APP results in Aβ. In contrast, in the non-amyloidogenic pathway APP is cleaved
by the α-secretase and further by γ-secretase (Figure 1.4)[81]. Alternative APP pro-
cessing can take place, as several other proteases can cleave APP at specific sites such
as asparagine endopeptidase (AEP), membrane-type matrix metalloproteases (MT5-
MMP) and meprin β [82].
The different proteolytic processing pathways are localised to different subcellular
compartments. While the non-amyloidogenic pathway presumably occurs on the cell
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Figure 1.4. Cellular processing pathways of APP. APP can be proteolytically processed by two
different pathways: The non-amyloidogenic pathway includes proteolytic cleavage by α- and γ-
secretase, precluding Aβ generation. This pathway is initiated by α-secretase and produces APPsα
and the α-carboxyl-terminal fragment, α-CTF or C83. C83 can be further processed by γ-secretase
and produces P3 and AICD. The amyloigenic pathway involves β-secretase cleavage that produces
secreted APPsβ, and the β-carboxyl-terminal fragment, β-CTF or C99. C99 can be further cleaved
by γ-secretase, giving rise to Aβ and AICD. In Alzheimer’s disease Aβ forms oligomers that further
accumulate to plaques, a hallmark of the disease.
membrane, the amyloidogenic processing is taking place in the endosomal compart-
ment [83].
Proteolytic processing of APP produces Aβ which plays a central role in the patho-
genesis of AD, as its accumulation to oligomers, fibrils and plaques is a central hallmark
of the disease [65],[81]. Specifically, it is crucial to understand the source and the gen-
eration of Aβ in order to develop strategies for targeting its excessive abundance in
AD.
As the deposition of the APP cleavage product Aβ is a hallmark of AD, APP
expression and cleavage sites are in focus of attention. However, the physiological
function of APP still remains largely unknown [67].
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1.3.2 Functions of APP and its cleavage products
The proteolytic cleavage of APP gives rise to the Aβ peptide that is the component
of the amyloid plaques in AD patients. In order to profoundly understand the disease
and develop therapeutic strategies, decoding the physiological functions of APP and
its cleavage fragments is of major importance.
In addition to the numerous APP fragments with varying effects on neural func-
tion, also the APP full-length form has important functions [84],[64]. APP has an
impact on cell proliferation, differentiation, neurite outgrowth [85], cell adhesion and
synaptogenesis [67]. Moreover, it acts as a cell surface receptor [86] and growth factor
[87]. APP participates both intracellularly and extracellularly in diverse mechanisms
[67]: APP is also a typical cell surface G protein-coupled receptor (GPCR) [84] and
is important during the development of the brain [74]. Furthermore, the amyloid pre-
cursor protein intracellular domain (AICD) plays a role in numerous processes such
as nuclear signalling, transcriptional regulation, cell death, DNA repair and cell cycle
re-entry [88]. Both the amyloidogenic and the non-amyloidogenic pathways are able
to generate AICD.
APP by itself does not play an essential role in development, as APP-KO mice
are viable and fertile. However, APP-KO mice display reduced locomotor activity and
grip strength, reactive gliosis and reduced body weight and neuronal plasticity deficits
[89],[64].
Functions of APP at the synapse
APP and APP cleavage products play important roles in numerous synaptic processes
[64]. On the pre- and postsynapse, APP is also suggested to play a role in cell adhesion
thereby stabilising synapses [90],[84]. In hippocampal neurons, cell-associated APP
accounts for neuron viability, axonogenesis, and arborisation. Furthermore, secretory
products of APP modulate axon growth, dendrite branching and counts [91].
Moreover, APP is implicated in modulation of synaptic transmission by regulating
the receptor composition at the synapse: Increased levels of NR2A and NR2B sub-
units of the NMDA receptor are associated with increased levels of APP and its other
family members [92],[93] and full-length APP enhances synaptic activity, synapse for-
mation, and dendritic spine formation [94]. In contrast, the lack of APP in autaptic
hippocampal neurons results in increased AMPA and NMDA receptor currents [95].
Furthermore, APP is essential for constitutive and adaptive synaptic plasticity of
dendritic spines [96],[97]. This APP-dependent plasticity is regulated by the gliotrans-
mitter D-serine implicating a role of astrocytes [96].
Diverse levels of the cleavage product Aβ can have different consequences on neu-
ronal function. High levels are well known for their detrimental effects in synaptic
function leading to dementia [36], while picomolar levels of monomeric and oligomeric
Aβ have a positive modulatory effect on neurotransmission and memory [98].
Other APP cleavage products such as secreted APPα (APPsα) are important for
excitatory principal neurons for mediating normal dendritic architecture, spine density
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and morphology, synaptic plasticity and cognition. APPsα is derived from the non-
amyloidogenic processing pathway (Figure 1.4)[84]. APPsα is generated by α-secretase
processing and thereby secreted into the extracellular space where it is associated
with neuronal and synaptic function [99],[100]. It is neuroprotective, neurotrophic
and regulates cell excitability and synaptic plasticity [101],[102]. A neuroprotective
role of APPsα in stress signalling, dendritic degeneration and neuronal cell death has
also been reported [103]. APPsα has been shown to have trophic effects, for instance
knock-in of APPsα into APP-KO animals is sufficient to prevent the reduced spine
density observed in APP-KO mice [104]. Moreover, APPsα knock-in in APP-deficient
mice can rescue anatomical, behavioural and electrophysiological phenotypes [101].
Especially the extracellular part of APP seems to be important for synapse func-
tion, as mice lacking the intracellular domain of APP show no plasticity deficits and
increased levels of APP at the cell surface [101].
Functions of APP associated with Ca2+ homeostasis
APP and its cleavage products are associated with mitochondria and endoplasmatic
reticulum (ER) function. Both organelles operate in a strict interplay and their dysreg-
ulation is also linked to AD [105]. As energy deficiency and mitochondrial dysfunction
have been recognised as a prominent, early event in AD, it is crucial to understand
the physiological role of APP and its cleavage products in energy metabolism.
Full-length APP and its cleavage products play a role in mitochondrial function
when they localise in mitochondria-associated ER membranes [106] and in the mito-
chondrial import channel [107]. Moreover, once inside mitochondria Aβ interacts with
several proteins inside the organelle which leads to mitochondrial dysfunction [108].
APP and its cleavage products are important for mitochondrial integrity: Over-
expression of APP and thus overproduction of Aβ has been shown to play a role in
mitochondrial morphology, function and protein composition [109]. Alterations in the
electron transport chain and energy production have been reported in mouse models
of AD [70].
In more detail, APP contains a mitochondrial targeting signal and it forms stable
complexes with the translocase of the outer mitochondrial membrane 40 (TOM40).
TOM40 acts as an import channel and forms a complex with the translocase of the
inner mitochondrial membrane 23 (TIM23). Together, they are regulating the import
of proteins into the mitochondrial lumen [107].
It is suggested that AICD is involved in cytosolic calcium ion (Ca2+) homeosta-
sis and energy production, as decrease or lack of AICD leads to an enhanced Ca2+
concentration in the cytosol, reduced ATP levels and mitochondrial hyperpolarisation
[110]. Reduced levels of AICD were shown to diminish Ca2+ signalling via a mecha-
nism that implicates ER Ca2+ store modulation [111]. These observations suggest a
tight interaction of ER and mitochondria and that impairment of one organelle might
entail imbalance of the whole Ca2+ homeostasis machinery. Studies investigating the
role of APP in terms of cellular Ca2+ homeostasis in APP-KO astrocytes revealed
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that resting cytosolic Ca2+ is not altered, whereas stimulated Ca2+ release from ER
is reduced [112].
Another aspect, that is linked to Ca2+ buffering and therefore to mitochondrial
function, is mitochondrial morphology. Mitochondria are highly dynamic structures
that adapt constantly to local energy demands. Hence, they undergo fission and
fusion and get transported to the locus where they are needed. Fragmentation of
mitochondria is associated with dysfunction and diseases [70]. Mitochondrial fission
arrest has been reported in AD [113] also suggesting an impaired balance between
fission and fusion [114]. It has been shown that functional KO of APP leads to a
fragmented morphology of mitochondria [115]. Likewise, overexpression of WT and
mutant APP causes fragmented structure of mitochondria and changed levels of fission
and fusion proteins such as DLP1, OPA1 and Fis1. Moreover, APP overexpression
leads to elevated reactive oxygen species levels, decreased mitochondrial membrane
potential and reduced ATP production [109].
Hence, APP and its cleavage products interact with organelles that are involved
in Ca2+ homeostasis.
1.4 Synaptic plasticity
Synapses are the specialised connecting sites that allow neurons to forward information
by communicating with each other. The human brain contains 1012 neurons which
themselves form thousands of synapses. The resulting great network of 1015 neuronal
connections reaches further complexity by the specialisation of individual synapses.
Synapses display diverse communication between pre- and postsynapse via transmit-
ters. Transmitters are released by the presynapse, diffuse through the synaptic cleft
and initiate diverse activation of the postsynapse. The complexity of the network
drives the various and sophisticated features of the brain such as perception, emotion,
thought, and behaviour [116].
Synaptic plasticity is a term for experience-dependent adjustments of synapses
that are manifested by morphological and molecular rearrangements in the pre- and
postsynaptic compartments. Thereby, neurons adapt to new conditions by strengthen-
ing or weakening synaptic pathways. This adaptation is considered as the underlying
mechanism of learning and memory [116]. Here, the term synaptic plasticity is fur-
ther specified in structural and functional plasticity depending on the experimental
approach. Neural circuits are configured by formation, elimination and morphological
adjustments of synapses. Thereby new connections are formed and preexisting ones
weakened, abolished and strengthened. These modifications are termed structural
plasticity. These processes are accompanied by molecular changes such as rearrange-
ments of synaptic components and gene expression adaptations [116]. When molecular
changes result in strengthening or weakening of synaptic signalling measured by mod-
ified neuronal activity, the term functional plasticity is used.
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1.4.1 Structural plasticity of dendritic spines
Structural plasticity of synapses refers to morphological changes that come along with
signalling alterations between pre- and postsynapse. For instance, the postsynapse
of excitatory glutamatergic synapses forms a distinctive dendritic spine that receives
excitatory input from the presynapse of pyramidal cells and many other principal
neurons [117].
A dendritic spine is a small (1–2 μm long) specialised protrusion of the dendritic
shaft. Dendritic spines were discovered in 1888 by Santiago Ramo´n y Cajal with
the Golgi staining method which was a groundbreaking revelation in the history of
neuroscience [118]. In dendritic spines, filamentous actin (f-actin) determines the
spine shape, arranges the postsynaptic signalling machinery, and promotes changes in
spine structure and spine stability [119]. Moreover, the postsynaptic density (PSD)
is a protein dense structure in the postsynaptic spine, close to the synaptic cleft that
receives the information from the presynapse (Figure 1.5).
Based on the morphology, different spine classes can be distinguished: thin spines
are fine and long and can have a small head; stubby spines have a large head without
a neck; mushroom spines have bulbous head and thin neck; filopodia are thin pro-
trusions without PSD [120] and are therefore classically not considered as dendritic
spine [121],[122]. The morphology of dendritic protrusions provides evidence about its
stability: Filopodia only exist for several hours and are very motile. Thin spines are
more stable than filopodia, but still less stable than mushroom spines.
During development dendritic spines form and turn over dynamically, while they
are stable for months and years in the adult brain. The stability of dendritic struc-
tures is important for accurate brain function and a dysregulation is associated with
psychiatric or neurodegeneative diseases [123]. Experience-dependent dendritic spine
plasticity (morphology, formation and elimination) provides the structural mechanism
for learning and memory. Hence, altered spine plasticity is a hallmark of injuries and
neurological diseases accompanied by intellectual disabilities [124].
Dendritic spines are playing a substantial role in modulating neuronal networks to
an extent that includes complex mechanisms such as learning and memory [125]. Their
electrical properties enable neural circuits to gain a high connectivity, with individually
integrated inputs in order to generate an emergent functional conglomerate [126].
In vivo two-photon microscopy reveals fundamental insights into spine plasticity, as
it allows chronic observation of the same dendritic spine [120], e.g. during experience-
dependent plasticity [127],[124] or during development of the brain [128].
Synaptic plasticity enables neuronal networks to function in a highly dynamic
manner. Thus, structural plasticity investigations of neuronal networks become a
targeted matter in neuron-associated diseases.
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1.4.2 Functional plasticity
Molecular rearrangements in the pre- and postsynaptic compartments can strengthen
or weaken synaptic signalling. The mechanisms underlying the various forms of long-
term potentiation (LTP) and long-term depression (LTD) are associated with diverse
functions both during development and forms of experience-dependent plasticity, in-
cluding learning and memory [129],[130]. During synaptic plasticity, receptor compo-
sition on the postsynaptic membrane undergoes changes that result in increased or
decreased transmission of synaptic signals.
The most compelling form of such plasticity is NMDAR-dependent LTP which is
widely studied in the Schaffer collateral-CA1 synapses of the hippocampus [130],[131],
[132],[133]. This mechanism involves AMPARs and NMDARs, the two major classes
of ionotropic glutamate receptors at the postsynaptic neuron [134].
In an experimental setting, this phenomenon can be achieved by different induc-
tion protocols implicating a strong electrophysiological stimulation of the presynapse
resulting in strong depolarisation of the postsynapse via alpha-amino-3-hydroxy-5-
mythyl-4-isoxazolepropionic acid receptor (AMPAR)[131]. During the depolarisation
of the postsynapse NMDARs get activated: Binding of glutamate to NMDARs to-
gether with depolarisation of the postsynaptic membrane releases the magnesium ion
(Mg2+) block of the NMDAR. The successional opening of the NMDAR channel pro-
motes entry of Ca2+ and rise of Ca2+ level in the postsynapse (Figure 1.5)[132],[135].
The resulting rise in Ca2+ within the dendritic spine also associates with further
downstream consequences that involve the modulation of the AMPAR function, its
trafficking to the postsynaptic membrane, and transcriptional modifications. This
complex process is regulated by a large number of proteins [132].
In contrast to LTP, prolonged NMDAR activation, that is below the threshold for
inducing synaptic potentiation, can induce synaptic depression: long-term depression
(LTD).
Long-lasting synaptic changes such as LTP are accompanied by cytoskeletal mod-
ifications of dendritic branches and spines [136].
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1.5 Astrocytes
Alongside with oligodendrocytes and microglia, astrocytes belong to the group of glial
cells which are important regulators of brain homeostasis [137]. They regulate the
volume and composition of the extracellular space, thus manage the brain environment.
Moreover, astrocytes also play a crucial role in regulating the blood brain barrier [138]
and are implicated in ion and metabolic brain homeostasis [139]. They have important
roles in key aspects of brain development and function, such as neuronal metabolism,
synaptogenesis, homeostasis of the extracellular milieu, or cerebral microcirculation.
Astrocytes are intercellularly coupled by gap junctions [140] which are relevant for
astrocytic and neuronal signalling. Gap junctions are crucial for glutamate transport
within the astrocytic network that depends on the release of glutamate from active
neurons [141]. During high neuronal activity and high metabolic demand, astrocytic
metabolic coupling is essential for maintaining glutamatergic synaptic transmission
[142].
The highly ramified non-overlapping processes of astrocytes contact the surround-
ing neuropil. It is estimated that one astrocyte might contact around 100 000 synapses
in hippocampal region CA1 in the rat brain [143]. In line, astrocytes play functionally
relevant roles in synaptic physiology and glial function is essential for properly oper-
ating neurons. Hence, glial dysfunction significantly contributes to brain pathology
[137].
1.5.1 The tripartite synapse
The classical view that brain functions are exclusively driven by neuronal activity is
obsolete, since accumulating evidence suggests a complex interplay of neurons and
astrocytes that constitutes and monitors the sophisticated functions of the brain. The
tripartite synapse refers to the concept that a synapse is a functional unit consisting of
pre- and postsynapse and an astrocytic perisynaptic process (Figure 1.5). Astrocytes
exchange information with the synapse, react to synaptic activity and also regulate
synaptic transmission. Thus, astrocytes are highly integrated in the procedure of in-
formation processing, transfer and storage by the nervous system. However, astrocytic
Ca2+ transients occur spontaneously and can be independent from synaptic activity,
but are also evoked by neurotransmitters released during synaptic activity [144],[145].
Hence, the elaborate brain functions emerge not only from the complexity of dif-
ferent synapse types but also from the balanced activity of a network of neurons and
synapse associated glia cells [146],[144],[147].
Interaction of astrocytes with dendritic spines
The cellular basis of learning is constituted by experience-dependent changes of synap-
tic transmission, termed plasticity. This impressive feature of the brain is accompanied
by morphological adaptations of dendritic spines. This structural plasticity implicates
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the change of the cytoskeleton and thereby the appearance of the dendritic spine.
These modifications in spine size and density are thought to reflect changes in the
strength of synaptic transmission [148],[149].
Astrocytes operate in very close interaction with excitatory and inhibitory synapses
by structurally engulfing them, functionally reacting to neurotransmitters, and re-
leasing gliotransmitters that modulate synaptic transmission [150],[151]. Perisynaptic
astrocyte processes can favour synaptic modulation during development and in the
adult brain [152]. Thereby, astrocytic protrusions targeting synapses are very highly
motile, even more than dendritic spines [153]. It has been shown that activity of the
neuronal network regulates structural relationships between dendritic spines and as-
trocytic processes. This is associated with synaptic plasticity and consequences on the
astrocytic regulation of synaptic transmission. This phenomenon requires presynaptic
activity, mGluR activation, and G protein-coupled receptor (GPCR) mediated Ca2+
elevations in astrocytes [152].
3D reconstructions of synapses in the hippocampus have described higher astrocyte
coverage of thin spines than of larger spines. These findings suggest selective synapse-
astrocyte interaction in dynamic and forming spines, rather than in persisting ones
[154].
As astrocytes are extensive and close interactors of synapses, disruption of this
relationship has profound consequences ascribed to numerous disorders [155],[156].
Hence, it is important to understand the interplay physiologically in order to selectively
target the disease-related disturbances.
Figure 1.5 (preceding page). The tripartite glutamate synapse. The glutamatergic tripartite
synapse comprises a presynaptic terminal, a postsynaptic spine, and an astrocytic process. When
an action potential reaches the presynapse, voltage gated Ca2+-channels (VGCC) open and allow
Ca2+ influx in the presynaptic compartment. Following, vesicles filled with the neurotransmitter
glutamate fuse with the presynaptic membrane and release the transmitter into the synaptic cleft.
Glutamate binds to AMPA receptors, which function as a Na+-channel, leading to depolarisation
of the postsynaptic membrane. Binding of glutamate to NMDA receptors additionally results in
influx of Ca2+ which leads to further signalling cascades: towards the nucleus implicating gene
expression modulation and travelling of AMPA receptors to the postsynaptic membrane increasing
the sensitivity to glutamate. For activation of the NMDA receptor, a certain level of depolarisation
of the postsynapse and binding of D-serine is required for potentiation of the receptor. The
adjacent astrocyte plays a role in modulation of synaptic signalling: glutamate is cleared from
the synaptic space through amino acid transporters (GLAST and GLT-1). Moreover, D-serine is
relased in an activity-dependend manner via vesicles that require Ca2+ elevations in the astrocyte.
D-serine is produced from L-serine by serine racemase. L-Serine is produced in astrocytes shuttles
to neurons through alanineserinecysteine transporter 1 (asc-1) and is converted into D-serine by
serine racemase. D-serine shuttles from neurons to astrocytes, where it is packed in glial vesicles
until it is released. D-serine is removed from the synaptic cleft via ASCT and asc-1 transporters.
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The role of astrocytes in synaptic signalling and plasticity
Astrocytes integrate and process synaptic information and control synaptic transmis-
sion. They react to neuronal activity and neurotransmitters by activating metabotropic
receptors. This in turn can release gliotransmitters such as ATP, D-serine, glutamate
and GABA which modulate neuronal activity [144]. For instance, synaptic transmis-
sion is modulated by astrocyte-derived ATP or its metabolite adenosine implicated in
sleep and cognition [157].
In general, astrocytes function in slower time dimensions than neurons. While
one action potential has a duration of 1 ms, astrocytic Ca2+ signals last several sec-
onds. Also the influence on synaptic transmission is a transient control of the synaptic
strength during seconds [158],[144]. Thereby, astrocytes contribute to synaptic plas-
ticity such as LTP during which the release of gliotransmitter D-serine is crucial for
the generation of LTP [159]. This is taking course via D-serine binding to the glycine-
binding site of neuronal NMDAR.
Astrocytes control their membrane potential via inward rectifier K+ (Kir) chan-
nels [160]. The potential is close to the equilibrium potential of K+. Thus, when
extracellular K+ rises, K+ ions flow into astrocytes through these inward rectifiers.
Astrocytes express neurotransmitter glutamate [161] and GABA [162] transporters.
Thereby, astrocytes do not only participate in modulating synaptic transmission by
clearing the extracellular space from neurotransmitters but also by providing the presy-
napse with a recycled source of transmitters [142]. For instance, the glutamate that
is taken up by astrocytes is converted into glutamine which is then released to the
neurons modulating neuronal activity [163],[142].
During high neuronal activity and high metabolic demand, astrocytic metabolic
coupling is essential for maintaining glutamatergic synaptic transmission [142]. More-
over, astrocytes are highly involved in energy supply of neurons. They take up glucose
and either store it as glycogen or metabolise it to lactate [164] releasing either one or
the other when needed.
1.5.2 Ca2+ signalling in astrocytes
Astrocytes exhibit spontaneous and synaptically evoked Ca2+ signals [144]. The
synaptically evoked Ca2+ signals occur in most brain areas and in response to the re-
lease of numerous neurotransmitters and factors such as norepinephrine, ATP, GABA,
glutamate, acetylcholine, nitric oxide, endocannabinoids [144],[165],[142]. Notably, the
common transmitter among astrocytes and neurons is glutamate which has modula-
tory effects on both cells [166].
The transmitters bind to high-affinity astrocytic metabotropic GPCRs in the astro-
cytic membrane that provoke inositol-1,4,5-trisphosphate (IP3) production and Ca2+
release from the endoplasmic reticulum (ER)[144],[165]. Moreover, transient receptor
potential A1 (TRPA1) channels at the cell membrane are implicated in Ca2+ signals
in astrocytes, as their opening allows Ca2+ influx from the extracellular space into the
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cell lumen [167]. The functional consequence of Ca2+ signals in astrocytes is the release
of gliotransmitter which have modulatory actions on other glial, neuronal or vascular
cells [165]. The release occurs via regulated exocytosis that depends on docking and
fusion of vesicles with the plasma membrane. This process requires Ca2+ and the
formation of the soluble N-ethylmaleimide-sensitive fusion protein attachment protein
receptor (SNARE) complex [168].
The consequences of astrocytic contribution to neuronal signalling are exceedingly
diverse: modulation of stimulation or inhibition of synaptic transmission, involvement
in LTP or LTD, heterosynaptic facilitation or depression and homeostatic plasticity
[142]. Astrocytes react to synaptic activity with Ca2+ elevations [169]. Moreover, it
has been shown that spontaneous astrocytic Ca2+ oscillations can spread as waves to
neighbouring astrocytes and initiate slowly decaying NMDA receptor-mediated inward
currents in adjacent neurons [170]. This indicates that astrocytes are involved in
neuronal ion homeostasis.
The Ca2+ signals in astrocytes can be of two different kinds: the somatic Ca2+
transients are differing from the ones in astrocytic protrusions. The Ca2+ events in
the soma are less frequent but of longer duration and larger in amplitude than those
in the processes [165],[171]. In the astrocyte processes the Ca2+ signals originate in
spatially restricted areas termed microdomains [172].
Within astrocytes, organelles are tighly associated with each other to regulate
intracellular Ca2+ levels. ER-induced Ca2+ rise is followed by increased mitochondrial
Ca2+ levels [173]. Glutamate release from astrocytes is also controlled by rising Ca2+
levels that are modulated by mitochondria [174].
While neurons have a certain resting potential and reach a threshold when they
elicit an action potential, astrocytes base their cellular activity on variations of Ca2+
concentration in the cytoplasm.
Astrocytic Ca2+ signalling modulates neuronal information in diverse spatiotem-
poral dimensions to reach a higher degree of brain integration. Thereby astrocytes
display a complex compartmentalisation and highly dynamic Ca2+ transients [165].
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1.6 Methodology
In order to answer the neurobiological questions concerning the physiological role
of APP in synaptic plasticity associated with astrocytic function, diverse technical
approaches were made: intracellular and extracellular electrophysiological recordings
of neurons, immunohistological stainings, region-specific delivery of viruses encoding
different genetic tools, primary astrocyte cultures, ex vivo confocal laser scanning
microscopy, ex vivo two-photon Ca2+ imaging.
1.6.1 Two-photon microscopy
Imaging of living tissue for detailed visualisation of biological processes and structures
is of crucial benefit for decoding biological complexity. This advance of technical tools
enables us to better understand physiology and pathophysiology in neuroscience. Flu-
orescent labelling and modern microscopy allows selective visualisation of molecules.
Especially, the technique two-photon microscopy enables imaging studies of specific
protein localisation and of the structure and function of living single cells in intact
tissue [175], [176]. Two-photon microscopy enables high resolution imaging deeply in
the tissue in 3D with low phototoxitity and high sensitivity at several time points
[177]. The technique applied on biological samples was firstly described by Denk and
colleagues [178]. Hereby, the excitation of the fluorophore in the tissue is taking place
by nearly simultaneous absorption of two photons. The photons feature a long wave-
length close to infrared and are therefore of low energy. The addition of two photons
results in an excited energy state and elicits a photon of higher energy than the exciting
photons (Figure 1.6A). This non-linear effect of two-photon absorbtion (Figure 1.6B)
increases the excitation probability by high light intensity [179]. Hence, a specialised
laser is required which is typically a ultrafast pulsed Titanium-sapphire (Ti:sapphire),
with a pulsing rate of ∼100 MHz. Multiphoton absorption is termed nonlinear because
the absorption is of higher power than first power of the light intensity [179].
One advantage of two-photon microscopy is longer wavelength laser light that is
less absorbed and scattered, therefore it can penedrate the tissue more deeply and
is additionally less phototoxic. Moreover, the excitation only takes place in a focal
volume which additionally reduces phototoxicity and bleaching. Furthermore, also
scattering photons are collected, as there is no pinhole that blocks scattered photons,
in contrast to a confocal microscope [180],[181],[182].
One-photon microscopy with linear absorption requires one higher-energetic pho-
ton with smaller wavelength (typically blue or green) and is more scattered in the
tissue (Figure 1.6A). Confocal laser scanning microscopy applies one-photon excita-
tion and is also based on optical sectioning. Fluorophores get selectively excited by
a spatially restricted laserbeam. The laserbeam scans the probe which consecutively
excites image points. The emmited light from the fluorophores passes a pinhole that
blocks scattered light outside the focal plane before it reaches the detector [182].
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Figure 1.6. One- and two-photon microscopy. (A) Illustration of the fluorescence excitation
by one and two-photon absorption in a simplified Jablonski diagramme. The one-photon excitation
(1P, blue) is described as a photon of a short wavelength (blue) gets absorbed by a molecule
which promotes it to an excited state and when it returns to its ground state, a photon of a
slightly lower energy gets emitted (green). The two-photon excitation (2P, red) takes advantage
of two photons of half the energy/double wavelength arriving nearly simultaneously (∼0.5 fs) at
a molecule where they combine their energy for promoting the molecule to an excited state. For
this nonlinear effect a very high photon density is needed. (B) Light cone of 1P (left) and 2P
(right) excitation. 1P excitation is taking place within the entire cone of the focussed light beam.
In contrast, 2P excitation is confined to a perifocal region, as sufficient photon density is only
given there. (C) Nonlinear laser-scanning microscope. A Ti:Sa laser provides the photon density
necessary for nonlinear excitation in near-infrared ultrashort pulses. The acousto-optic modulator
(AOM) regulates the intensity and a telescope the size of the laser beam. The scan mirrors and
several lenses direct the laser beam that is then focused on the specimen by the objective. The
emitted fluorescence is separated from the excitation light and directed to photomultiplier tubes
(PMTs) via dichroic mirrors. Emission filters in front of the PMTs ensure detection of a specific
wavelength.
1.6.2 Ca2+ imaging
Ca2+ is a ubiquitous signalling molecule that is mediating various cellular processes,
ranging from development and differention to cell death [183],[184]. Sources and sinks
of intracellular Ca2+ can be channels in the plasma membrane, the ER and mitochon-
dria. Ca2+ concentration gradients (outside ∼2 mM, cytosol ∼100 nM), created by
energy-dependent Ca2+ transport across cellular membranes promote the conditions
for Ca2+ signalling [185]. Free and active cytosolic Ca2+ can bind to Ca2+ buffering
proteins in the cytosol and can initiate signalling to the nucleus modulating transcrip-
tion [183].
In order to visualise the alternating levels of cellular Ca2+, highly Ca2+-selective
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chelators fused to a fluorescent molecule are nowadays employed. The most recent
breakthrough are protein-based genetically encoded Ca2+ indicators (GECIs) that are
based on green fluorescent protein (GFP) [186] and calmodulin [187],[188]. GECIs
translate Ca2+ binding into an optical signal, as Ca2+ binding changes the optical
properties of the protein [189]. Spatial and temporal resolution of Ca2+ processes can
be achieved, as GECIs can be targeted to specific cell types or subcellular compart-
ments [190],[189]. There are two different kinds of GECIs: I) FRET-based indicators
change their conformation when Ca2+ is binding in order to induce Fo¨rster resonance
energy transfer (FRET). This leads to a shift in emitted wavelength (e.g. from 480 nm
to 530 nm). II) Single fluorophore GECIs are high-affinity Ca2+ indicators composed
of a single GFP fused to calmodulin (CaM). The so-called GFP-based Ca2+ probe
(GCaMP) provides a low signal-to-noise ratio [191],[188].
The latest generation of GCaMPs are GCaMP6 that bind Ca2+ with ultrasensitive
affinity and provide new spatial and temporal resolution of Ca2+ transients [192].
A modified membrane-tethered GCaMP (GCaMP-Lck) allows visualisation of Ca2+
fluctuations in small volume compartments, such as near the cell membrane and in
distal and ramified cell processes of astrocytes [193]. GCaMP-Lck can be expressed via
an adeno-associated virus (AAV) [194] or in a genetically modified mouse line (Figure
1.7)[195],[196].
A recent 3D Ca2+ imaging study of a whole astrocyte revealed that most of the
basal Ca2+ activity occurs in the processes, some in the endfeet, while small propor-
tion is detectable in the soma [171]. Thereby, the gliapil constitutes ∼75% of the
astrocytic volume [171]. In order to understand the role of APP in Ca2+ signalling
in the perisynaptic sites of astrocytes, a GCaMP6-Lck was used in APP-KO animals
and by that two-photon microscopy [177] allows visualisation of Ca2+ transients in the
intact tissue.
Figure 1.7. Lck-CaMP. Single-fluorophore genetically encoded Ca2+ indicator (GECI) that is
tethered to the plasma membrane. Binding of Ca2+ to GCaMP leads to an increase in emitted
fluorescence.
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1.7 Aim of this thesis
The aim of this thesis is to decipher the physiological role of astrocytic APP in synaptic
plasticity with regard to neuronal function and the associated astrocytic contribution.
Even though the presence of APP in astrocytes has been proven, the investigations of
APP functions have been mainly confined to neurons. As astrocytes are active partners
in neuronal signalling and comply with other tasks related to brain homeostasis, their
adequate function is of utmost importance. Understanding the physiological role of
APP in the entire brain is essential for fundamental biology and in regard to potential
therapeutic strategies for the treatment of AD.
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Chapter 2
Results
2. Results
2.1 The role of APP in synaptic plasticity in
the cortex and hippocampus
2.1.1 APP is crucial for cortical dendritic spine plasticity
without consequences on NMDA/AMPA receptor
currents
Dendritic spines are sites of input typically found on excitatory neurons. Synaptic
activity determines their formation, plasticity, and sustainment [197]. Hence, they are
of major importance for the connection of neuronal circuits [117]. In order to examine
the physiological function of APP on synaptic function in the cortex, a constitutive
knock-out (KO) mouse model of APP was used that lack APP in every cell type
[198],[101].
Chronic in vivo two-photon imaging investigated the plasticity of dendritic spines
in layer I/II of layer V pyramidal neurons in the somatosensory cortex of adult APP-
KO mice [96]. Reduced spine turnover rate (formation and elimination) was observed
in APP-KO animals in comparison to wild type (WT) mice in standard environment.
When exposed to enriched environment, WT mice displayed increased spine density
which could not be observed in APP-KO [96]. These observations came along with
decreased thin spine and increased mushroom spine proportion.
It has been shown that human AD cases and AD animal models display in-
creased levels of the endogenous NMDAR co-agonist D-serine in the brain and the
cerebrospinal fluid (CSF) [199]. Moreover, APPsα and Aβ is suggested to induce D-
serine production and release from glia cells [200],[201]. For this reason, extracellular
and total D-serine levels were investigated in the cortex of APP-KO mice. Decreased
extracellular but increased intracellular levels were found, suggesting a release problem
in the absence of APP [96].
Here, the application of D-serine via drinking water was tested whether it could
be of benefit for the spine plasticity impairments in APP-KO mice. Indeed, the treat-
ment with D-serine increased the spine turnover rate in standard environment and
spine density in enriched environment which correlated with increased thin spines and
decreased mushroom spines [96].
These observations raised the questions whether APP-KO mice display alterations
in excitatory synaptic transmission in terms of decreased NMDAR currents, as D-
serine potentiates NMDARs by binding to the glycine binding site and NMDARs have
been shown to be increased in mushroom spine type [202].
For functional investigation whether NMDAR density is altered in principal neu-
rons of the cortex of APP-KO animals, evoked NMDAR and α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPAR) currents were recorded and put
into ratio. Therefore, acute coronal brain slices of 300 μm were prepared from 3-months
old APP-KO and WT mice. After recovery, the slice was placed in a submerged record-
ing chamber containing picrotoxin for blockage of inhibitory currents. A stimulation
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Figure 2.1. NMDA/AMPA recordings in the cortex of APP-KO mice. (A) Illustration of
the experimental setting of evoked NMDA/AMPA EPSC in the acute brain slice. The stimulation
electrode (red line) was placed in close proximity to the soma of layer V pyramidal neurons. Follow-
ing, one pyramidal neuron was patched in the whole cell patch mode (black lines) and stimulated
EPSCs were recorded. (B) Top: Illustration of NMDA currents at different holding potentials (-90
to +40 mV). Black circle indicates the 40 ms after the stimulation as measurement point of the
NMDAR current amplitude. Bottom: NMDA current amplitude at different holding potential in
slices of WT and APP-KO animals with common aCSF (2 mM MgCl2) and low Mg
2+ aCSF (0.5
mM MgCl2); n = 2-6.
electrode was placed in close proximity (layer III/IV) to the soma of layer V pyrami-
dal neurons. Subsequently, the adjacent soma was patched in whole-cell configuration
(Figure 2.1A) from which excitatory postsynaptic currents (EPSCs) were recorded. An
increase in current after stimulation (stimulus response) verified neuronal connection
to the patched neuron. Firstly, the artifical cerebrospinal fluid (aCSF) conditions were
tested for ideal investigation of NMDAR currents. As NMDARs harbour a Mg2+ block
inside the channel, which is released upon reaching a certain depolarisation threshold,
the NMDAR current was tested under two aCSF conditions: commonly used 2 mM
MgCl2 and low 0.5 MgCl2. The neuron was clamped at different holding potentials
from -90 mV to +40 mV investigating the slower NMDAR component of the response
current amplitude 40 ms after the stimulus. Under normal MgCl2 conditions, the
NMDAR current amplitude was very low and barely increased with increasing hold-
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Figure 2.2. NMDA/AMPA and paired-pulse currents do not differ in APP-KO mice. (A)
Example traces for determination of the NMDA/AMPA EPSC ratio at -90 mV and + 40 mV. Red
line shows the position of the AMPAR response peak at -90 mV. This position is used for the
AMPAR current value in the recording at +40 mV (red dot). The NMDAR current value is taken
from the mean of 40 to 50 ms after the stimulation (red square, mean of 10 ms). (B) Bar graph of
the NMDA/AMPA EPSC ratio of WT and APP-KO animals. Two-tailed t-test, t(29) = 0.4178; p
= 0.679; n = 14-17. (C) Example traces of paired-pulse recording with 30 ms inter pulse interval.
(D) Bar graph of the PPR of the response amplitude of the second peak/first peak of WT and
APP-KO. Two-tailed t-test, t(13) = 0.6115; p = 0.5514; n = 5-10.
ing potential (Figure 2.1B) in APP-KO and WT. When recordings were performed
under low MgCl2 conditions the amplitude of the NMDAR current was larger and
remarkably changing over the different holding potentials (Figure 2.1B). Hence, the
subsequent NMDA/AMPA recordings were obtained with low Mg2+ aCSF.
Four stimulated transients were consecutively recorded at -90 mV in order to define
the position of the AMPAR response peak. Subsequently, four stimulated transients
at +40 mV were recorded for a combined AMPAR and NMDAR current of which
the AMPA response amplitude could be determined from the position of the peak
at -90 mV (Figure 2.2A, red line and dot). The NMDAR current amplitude was
employed from 40 to 50 ms after the stimulus artefact (Figure 2.2A, red square).
The ratio of NMDAR and AMPAR current amplitude of WT and APP-KO did not
reveal any differences (Figure 2.2B)(mean ± SEM: WT = 1.184 ± 0.07405; APP-KO
= 1.142 ± 0.06896; p >0.05). Moreover, paired-pulse fascilitation (PPF) recordings
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were performed with a stimulus interval of 30 ms. PPF is a short form of synaptic
plasticity: It is a phenomenon of an increase of the 2nd EPSC when the stimulation
closely follows a prior stimulation. PPF arises due to increased presynaptic Ca2+
concentration resulting in a greater release of neurotransmitters from the presynapse
that is measureable as increased 2nd EPSC. The paired-pulse ratio (PPR) of 2nd and
1st peak was unchanged between WT and APP-KO pyramidal cells (mean ± SEM: WT
= 1.323 ± 0.1358; APP-KO = 1.409 ± 0.07358 ; p >0.05)(Figure 2.2C,D) indicating
unchanged presynaptic release.
The lack of APP does not result in a change of NMDA/AMPA ratio and PPR in
layer V pyramidal cells of the somatosensory cortex in contrast to the observed spine
plasticity deficits in APP-KO. Hence, APP is crucial for dendritic spine plasticity
without consequences on synaptic signalling in terms of NMDA/AMPA density and
PPF currents.
2.1.2 Hippocampal long-term plasticity depends on the
presence of APP and cannot be restored by glio-
transmitter D-serine
It has been shown that impaired spine plasticity in the cortex of APP-KO animals
could be related to reduced levels of D-serine [96] and that astrocytic D-serine is crucial
for the induction of LTP [159]. The described LTP reduction in APP-KO animals
[101],[203] was hypothesised to result from a reduction of D-serine in the hippocampus.
Hence, a LTP rescue after D-serine application was tested, as demonstrated before
[167],[159].
Acute sagital brain slices of 350 μm thickness from 3-months old mice were used
for local field LTP recordings in the Schaffer collateral projections to CA1 area of
the hippocampus. Two stimulation electrodes were placed in the Schaffer collaterals
stimulating the fibers in both directions (anterograde and retrograde). A recording
electrode was positioned between the stimulation electrodes receiving anterograde and
retrograde input from both sides (Figure 2.3A). The LTP protocol defined a 20 min
stable baseline, followed by LTP induction by tetanus stimulation (100 pulses during
1s) and further LTP recording over 60 min. For the analysis, the slope of the field
potential was taken into account (Figure 2.3A) and the change normalised to the
baseline is displayed in percent. The recordings confirmed a LTP reduction in APP-
KO animals (Figure 2.3B) (mean ± SEM in %: WT = 136 ± 4.082; APP-KO =
120.8 ± 3.339; p <0.05). However, the lack of APP did not alter presynaptic release
probability examined by PPF with inter-pulse intervals of 20, 30, 50, 75, 100 and 200
ms (Figure 2.3C)(PPR mean ± SEM: 20 ms: WT = 1.657 ± 0.07693; APP-KO =
1.564 ± 0.04944. 30 ms: 1.864 ± 0.05692; APP-KO = 1.84 ± 0.0604. 50 ms : WT
= 1.915 ± 0.05112; APP-KO = 1.938 ± 0.06043. 75 ms: WT = 1.877 ± 0.02832;
APP-KO = 1.868 ± 0.06112. 100 ms: WT = 1.819 ± 0.01758; APP-KO = 1.799 ±
0.04419. 200 ms: WT = 1.539 ± 0.03202; APP-KO = 1.537 ± 0.02736. n = 6 animals,
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Figure 2.3. LTP is reduced in APP-KO mice. (A) Illustration of the experimental setting of
local field long-term potentiation (LTP) recordings in the hippocampus of acute brain slices. The
confocal picture with sparsely labelled neurons serves for demonstrating the electrode positions.
Two stimulation electrodes are placed in the CA1 region on the Schaffer collaterals, one closer
to CA3 and one more far from CA3. Then, the recording electrode is placed between the two
stimulation electrodes detecting the local field potential that are elicited from both stimulation
electrodes (arrows). The example trace on the left shows the analysis of the local field potential
by a straight line along the slope. The change in the slope grade is taken into account for LTP
analysis. Scale bar = 500 μm. (B) The LTP is reduced in APP-KO mice in comparison to WT.
Analysis of % employed from min 50 to 60. One-way ANOVA: p = 0.0244; n = 16-17 slices. (C)
Paired-pulse facilitation recording with different stimulus intervals plotted along the x-axis. A ratio
of the 2nd and the 1st slope serves as facilitation interpretation. There is no difference between
APP-KO and WT (n = 6 animals). (D) Input/ouput (I/O) curve of the response slope along
stimulus increase 0-4 mV. There is no difference in the response to stimuli increase between WT
and APP-KO (n = 6 animals).
p >0.05).
Moreover, the amplitude and the slope of the input/output (I/O) measuring the
local field potential response to increasing stimuli did not reveal a change between
WT and APP-KO animals (Figure 2.3D). These findings suggest a plasticity related
phenotype that is independent of presynaptic release or basic postsynaptic stimulus
response.
30
2.1 The role of APP in synaptic plasticity in the cortex and hippocampus
D-serine in aCSF (acute)
* *
sl
o
p
e 
%
chronic D-serine treatment
S
R
100
110
120
130
140
150S
LTPCA
B
recording chamber
W
T
AP
P-
KO
AP
P-
KO
 D
se
r a
cu
te
W
T D
se
r a
cu
te
W
T D
se
r c
hr
on
ic
AP
P-
KO
 D
se
r c
hr
on
ic
Figure 2.4. Reduced LTP in APP-KO hippocampus cannot be rescued by D-serine appli-
cation. (A) Illustration of the experimental setting of acute 10 μM D-serine application via aCSF
perfusion in der submerged recording chamber, containing the acute slice with stimulation and
recording electrode. (B) Illustration of chronic 5.2 mM D-serine application via the drinking water
over 4 weeks. (C) LTP recordings of WT, APP-KO without treatment, D-serine in the recording
chamber (acute) and D-serine treatment (chronic) via drinking water. APP-KO animals display
reduction in LTP in comparison to WT untreated (WT vs. APP-KO: F(5,94) = 1.468, p = 0.0244).
WT animals treated with D-serine (WT treated with D-serine vs. APP-KO: F(5,94) = 1.435, p =
0.0237). One-way ANOVA, n = 16-21.
In order to test whether D-serine can rescue the reduction of LTP in APP-KO
animals, 10 μM D-serine was acutely washed in the recording chamber (Figure 2.4A)
or chronically applied via the drinking water for 4 weeks (Figure 2.4B). Neither of the
D-serine applications could rescue the phenotype of APP-KO (Figure 2.4C) (mean ±
SEM: WT = 136 ± 4.082; APP-KO = 120.8 ± 3.339; WT D-serine acute = 124.1
± 3.446; APP-KO D-serine acute = 122.5 ± 3.275; WT D-serine chronic treatment
= 135.2 ± 4.128; APP-KO D-serine chronic treatment = 125.5 ± 3.159; p >0.05).
Surprisingly, acutely applying D-serine in the recording chamber resulted in a slight
decrease of LTP in the WT which was neither significantly different to WT nor to
APP-KO. In contrast, chronic treatment with D-serine in the drinking water had no
effect on LTP in WT slices (significantly different to APP-KO)(Figure 2.4C).
In conclusion, APP is not essential for basic synaptic transmission involving pre-
and postsynapse (PPF, I/O) but for functional plasticity (LTP) in the hippocampus.
The ineffective application of D-serine indicates that other or additional factors are
involved.
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2.1.3 Conditional KO of APP in astrocytes influences
spine density and morphology in the cortex and
hippocampus
Morphology and distribution of dendritic spines are dynamically and tightly regulated
[125] and profoundly influenced by neuronal activity [204]. Astrocytes are in close
proximity to synapses and are supporting partners in synaptic function [144].
Previous studies report a crucial role of APP in spine stability in the cortex and
hippocampus [205],[206],[97],[96]. However, the role of astrocytic APP in spine sta-
bility in the context of the tripartite synapse has been neglected so far. Hence, the
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Figure 2.5. Conditional KO of APP in adult astrocytes surrounding GFP-M positive neu-
rons. (A) Confocal picture of the cortex and hippocampus illustrating injection sites: Grey line indi-
cates injection needle and crosses the injection sites where AAV Brainbow and AAV GFAPCreERT2
were applied in APP+/+ x GFP-M and APPfl/fl x GFP-M. Tamoxifen application (10 weeks later)
activated Cre recombinase which entailed fluorophore expression and KO of APP. Another 10 weeks
later, the perfused brain was used for ex vivo confocal studies. Scale bar = 1000 μm. (B) Example
picture of sparsely labelled dendrites passing through one astrocyte lacking APP in the cortex (I),
hippocampus CA1 basal (II) and apical (III) region. Scale bar = 20 μm.
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question was raised which role astrocytic APP plays in spine density and morphol-
ogy. For this purpose, animals with a floxed APP gene locus [207] were bred with
eGFP-M animals expressing eGFP in a subset of principal neurons [208]. Stereotac-
tic injection of adeno-associated virus (AAV) encoding a floxed mCherry fluorophore
(AAV9 Brainbow, reporter virus) and GFAPCreERT2 (AAV5 inducible Cre expression
in astrocytes) in the hippocampus and cortex enables selective and conditional KO of
APP in astrocytes after tamoxifen application. After recombination, the mCherry
fluorophore is expressed and provides an indication of Cre recombinase activity and
therefore indicates KO of APP (Figure 2.5A). The sparse labelling of neurons with
eGFP was used for spine analysis on dendrites that are surrounded by a mCherry pos-
itive and APP deficient astrocyte. Hereby, the density and morphology of the basal
cortical dendrites and basal and apical dendrites of CA1 in the hippocampus were
investigated (Figure 2.5B).
The basal cortical dendrites did not display any alterations in spine density (mean
spines/μm ± SEM: WT = 0.9402 ± 0.05368; cAPP-KO = 0.9162 ± 0.06287, p >0.05).
However, the basal and apical dendrites of the hippocampus showed increase in spine
density when APP was knocked out in the surrounding astrocyte (mean spines/μm ±
SEM: basal WT = 1.38 ± 0.06862; basal cAPP-KO = 1.653 ± 0.07941; apical WT =
1.795 ± 0.07798; apical cKO = 2.067 ± 0.06255, p <0.05) (Figure 2.6B).
Classification of the spine types mushroom, thin and stubby spines, revealed de-
crease of thin spines in the cortex as a consequence of lack of APP in the adjacent
astrocyte (mean cortical thin spines/μm ± SEM: WT = 0.4858 ± 0.03673; cAPP-KO
= 0.3455 ± 0.03827, p <0.05). In contrast, the increase in spine density in the basal
and apical CA1 area exclusively resulted from elevated numbers of mushroom spines
(mean CA1 mushroom spines/μm ± SEM: basal WT = 0.7332 ± 0.04195; basal cAPP-
KO = 0.9566 ± 0.07516, p <0.05; apical WT = 1.034 ± 0.05337; apical cAPP-KO =
1.21 ± 0.05944, p <0.05) (Figure 2.6C).
The results depict an astrocytic role of APP in regulating structural plasticity of
excitatory synaptic spines varying across brain regions.
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Figure 2.6. Conditional KO of APP in adult astrocytes alters morphology and density of
dendritic spines. (A) Analysed example dendrites. Only the part of the dendrite passing through a
labelled astrocyte was analysed. Scale bar = 10 μm. (B) Bar graphs of spine densities (spines/μm)
on dendrites after conditional KO of APP (cAPP-KO) in the adjacent astrocyte. Spine density of
cortical dendrites is not changes between cAPP-KO and WT (t(49) = 0.2916, p = 0.7718, n =
23-28). Hippocampal dendrites display increase in spine density in cAPP-KO, CA1 apical (t(51)
= 2.731, p = 0.0087, n = 26-27) and CA1 basal (t(58) = 2.602, p = 0.0117, n = 30, two-tailed
Students t-test. (C) Morphological alterations of dendritic spines in cAPP-KO. Cortical dendritic
spines exhibit a decrease in thin spines in cAPP-KO (t(49) = 2.629, p = 0.0114, n = 23-28). In
the hippocampus dendrites show an increase in spines of the mushroom type both in apical (t(51)
= 2.19, p = 0.0311, n = 26-27) and basal (t(58) = 2.595, p = 0.012, n = 30, two-tailed Students
t-test) areas.
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APP-KO animals display a neuronal plasticity phenotype [64] that is supposedly as-
sociated with dysfunction of astrocytic Ca2+ signalling. For instance, reduced levels
of extracellular D-serine were associated with structural synaptic plasticity impair-
ments in APP-KO animals [96]. D-serine is Ca2+ dependently released by astrocytes
during functional synaptic plasticity [159],[167],[209], which was shown to be reduced
in APP-KO animals [101]. Moreover, primary APP-KO astrocytes display deficits in
Ca2+ homeostasis and energy supply [112],[110]. Generally, astrocytic Ca2+ increase
can be induced during synaptic activity by neurotransmitter or spontaneously in the
absence of neuronal activity [144]. It has been shown that stimuli for LTP induction
enhance the motility of synapse-associated astrocytic processes. This motility depends
on G-protein-mediated Ca2+ elevations in astrocytes [152].
Taken together, several lines of evidence suggest a crucial role of APP in astrocytic
Ca2+ signalling impacting synaptic function. Hence, spontaneous astrocytic Ca2+
transients and related mitochondrial function were investigated within fine perisynap-
tic processes of APP-KO astrocytes.
2.2.1 Investigation of spontaneous astrocytic Ca2+ tran-
sients in the hippocampus and cortex
As the focus of this thesis lies in aspects of communication between neurons and astro-
cytes in the view of the tripartite synapse, Ca2+ signals were measured in the highly
ramified processes of astrocytes that are the contact sites to neurons. Therefore, an
AAV GFAP Lck GCaMP6 encoding a membrane-tethered Ca2+ indicator GCaMP6
[194] was used. The virus was stereotactically injected in the hippocampus (dentate
gyrus and CA1) and overlying somatosensory cortex of 2-months old APP-KO and WT
control animals (Figure 2.7A). The brain was harvested for two-photon imaging of 350
μm acute coronal slices 4-5 months later. Acute brain slices were prepared as for LTP
recordings and transferred into the submerged recording chamber of the two-photon
microscope. The expression of the Ca2+ indicator was checked by epifluorescence and
an appropriate ROI (67 × 67 μm, 5 min, 2 Hz) in the cortex or hippocampus was
chosen for two-photon imaging (Figure 2.7A). The imaged astrocytes displayed Ca2+
elevations within small spatially restricted areas that lasted several seconds. Prepara-
tion for analysis included a shift correction followed by cropping the image sequence to
60 × 60 μm. For the analysis of the active areas (Figure 2.7B), termed microdomains,
the image sequence was filtered in 3D from the background noise. Next, a detection
threshold was set by projecting the image sequence along the time axis to a single
image of average intensity (AVG) and standard deviation (STD). The STD image was
added 3× to the AVG image and a threshold was defined. Subsequently, this threshold
was used for a summary and STD projection of the image sequence. The addition of
both threshold projections were filtered and gave rise of microdomains/ROIs that were
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applied onto the raw image series in order to extract the Ca2+ transients. Notably, not
all detected microdomains display transient activity. Only active microdomains were
manually selected and considered for analysis. The Ca2+ traces were further anal-
ysed in terms of Ca2+ event frequency and kinetics with the MiniAnalysis programme
(Figure 2.7B).
Imaging of perisynaptic astrocytic Ca2+ transients enables investigations of astro-
cytic activity as an important partner in synaptic function.
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Raw image sequence 3D noise reduction Projection along the time axis
AVG + 3xSTD
200 µm
CA1
1000 µm
0.2 ∆
F/F
60 s
ROI detection
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I
I
II
II
A
B
Threshold
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Figure 2.7. Analysis of astrocytic Ca2+ transients in the hippocampus and cortex. (A)
Expression pattern of astrocytic GCaMP6 after AAV transduction in dentate gyrus and CA1 of the
hippocampus and the somatosensory cortex. Squared insets: zoomed view of the imaging area
in the cortex (I) and CA1 area (II). Blue insets: imaging acquisition areas of 67 × 67 μm. (B)
Analysis for microdomain detection and Ca2+ transient extraction: The background noise in 3D
is subtracted from the raw image sequence. Next, average (AVG) and standard deviation (STD)
projections along the time axis are used for the individual activity threshold definition (AVG + 3
× STD). The threshold is employed for ROI detection from which Ca2+ traces are extracted from
the raw image sequence. Exemplified subset of transients in colour.
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Spontaneous astrocytic Ca2+ transients are impaired in the cortex of
APP-KO animals
Astrocytic active microdomain composition and their Ca2+ transients were imaged
in layer I/II of the somatosensory cortex in acute brain slices of WT and APP-KO
animals. The analysis revealed no difference in the number of active domains within
the image acquisition area (Figure 2.8A,B). Moreover, the microdomain size revealed
no significant alterations due to the lack of APP (mean ± SEM in μm2: WT = 85.92
μm2 ± 7.389; APP-KO = 78.73 μm2 ± 6.846, p >0.05) (Figure 2.8C,D).
The extracted Ca2+ transients (Figure 2.8E-J) displayed significantly reduced fre-
quency Ca2+ events in APP-KO animals (mean ± SEM in evt/min/domain: WT =
2.449 ± 0.207; APP-KO = 1.629 ± 0.1813; p <0.005)(Figure 2.8E,F). The amplitude
of the events (∆F/F) remained unchanged (Figure 2.8G)(mean ± SEM: WT = 0.08017
± 0.006467; APP-KO = 0.09327 ± 0.01338, p >0.05). The rise time was significantly
increased (mean ± SEM in ms: WT = 2281 ± 120.8; APP-KO 3046 ± 308.9; p <0.05)
in APP-KO while the decay time was not altered (Figure 2.8I)(mean ± SEM in ms:
WT = 4780 ± 377.4; APP-KO = 5126 ± 552.4; p >0.05). The area under the curve
(AUC) was also not changed (Figure 2.8J) (mean ± SEM in a.u.: WT = 5333834 ±
610869; APP-KO = 6692575 ± 1532647; p >0.05).
These findings illustrate a role of APP in regulating spontaneous Ca2+ transients
in the perisynaptic astrocytic protrusions in the cortex and might be an explanation
for synaptic plasticity dysfunctions in APP-KO.
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Figure 2.8. Altered spontaneous astrocytic Ca2+ transients in APP-KO cortex. (A) Exem-
plified activity profiles and distribution of active microdomains in WT and APP-KO cortex. Scale
bar = 10 μm. (B) Neither the number of active domains (Mann-Whitney test: p = 0.1373; U =
26.5; n = 9-10 slices) nor the microdomain size (C) is altered in APP-KO cortex (p = 0.9175; U
= 6399; n = 97-133 microdomain). (D) Frequency distribution of microdomain size (Kolmogorov-
Smirnov comparison: D = 0.0656; p = 0.964). (E) Example Ca2+ traces. (F) The frequency of
Ca2+ events is reduced in the APP-KO (p = 0.0041 (**); U = 11). (G) The amplitude of the
events (∆F/F) remains unchanged (two-tailed t-test. p = 0.3752; t(17) = 0.9107). (H) The rise
time is increased (p = 0.0281 (*); t(17) = 2.401), (I) decay time (p = 0.6054; t(17) = 0.5264),
and (J) area under the curve (AUC) are unchanged in APP-KO (p = 0.4037; t(17) = 0.8564; n
= 9-10 slices).
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Spontaneous astrocytic Ca2+ transients are impaired in the hippocam-
pus of APP-KO animals
Astrocytic active microdomain composition and their Ca2+ transients were imaged
in the stratum radiatum of the hippocampal CA1 area in acute brain slices of WT
and APP-KO animals. Analysis of the image sequences revealed no difference in the
number of active microdomains (mean ± SEM: WT = 10 ± 1.604; APP-KO = 12.09
± 1.455; p >0.05) (Figure 2.9A,B). However, the average microdomain size was larger
in APP-KO animals (Figure 2.9C) (mean ± SEM: WT = 80.97 ± 6.666; APP-KO =
95.91 ± 7.397; p <0.05) which became evident in the shift of the frequency distribution
(Figure 2.9D) (p <0.05). With regard to the kinetics of the Ca2+ transients, APP-
KO animals displayed reduced event frequency per active microdomain (Figure 2.9F)
(evt/min/domain mean ± SEM: WT = 2.189 ± 0.1541; APP-KO = 1,557 ± 0.2455;
p <0.05). The amplitude of the events (∆F/F) (Figure 2.9G)(mean ± SEM in ∆F/F:
WT = 0.09677 ± 0.008027; APP-KO = 0.07745 ± 0.0115; p >0.05), the rise time
(Figure 2.9H)(mean ± SEM in ms: WT = 2732 ± 136.1; APP-KO = 2756 ± 184.5;
p >0.05) and decay time (Figure 2.9I)(mean ± SEM in ms: WT = 5375 ± 561.4,
APP-KO 5529 ± 634, p>0.05) remained unchanged between WT and APP-KO. The
area under the curve was also unaltered among the two genotypes (Figure 2.9J)(mean
± SEM in a.u.: WT = 6527615 ± 1046761; APP-KO = 4940486 ± 1163954, p >0.05).
These results depict a role of APP in regulating spontaneous Ca2+ transients in
the perisynaptic astrocytic protrusions in the hippocampus and might be associated
with the synaptic plasticity dysfunctions in APP-KO.
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Figure 2.9. Altered spontaneous astrocytic Ca2+ transients in APP-KO hippocampus. (A)
Illustrative activity profiles and distribution of active microdomains in WT and APP-KO CA1. (B)
There is no difference in the number of active microdomains (two-tailed t-test: p = 0.3570; t(23)
= 0.9401; n = 11-14 slices). (C) APP-KO animals display increase in microdomain size (Mann-
Whitney test: p = 0.036; U = 7942; n = 133-140 microdomains.) and (D) a frequency distribution
shift (Kolmogorov-Smirnov comparison of two data sets: D = 0.1722; p = 0.031). (E) Example
Ca2+ traces. (F) The frequency is reduced in APP-KO (p = 0.0328; t(23) = 2.272). (G) The
rise time (p = 0.9174; t(23) = 0.1049), (H) the decay time (p = 0.8573; t(23) = 0.1818), and
(J) the area under the curve (p = 0.1492; U = 50; n = 11-14 slices) are unchanged in APP-KO.
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2.2.2 Altered mitochondrial network integrity in APP-
KO astrocytes
In the brain, astrocytes interact with closely associated synapses and with each other.
Within this complex network they show alterations of spontaneous Ca2+ transients as
a consequence of lack of APP.
The integrity of Ca2+ transients in the microdomains of astrocytes is strongly
associated with mitochondrial localisation and function [195],[210]. In order to better
understand the cause of this finding, primary astrocytic cultures were investigated
for a potential mitochondrial phenotype. First of all, astrocytes were isolated from
three pups at postnatal day 3 (p3) (Figure 2.10A) and the lack of APP was confirmed
with western blot analysis by immunolabelling against the C-terminus and N-terminus
of APP (Figure 2.10B). The slight bands in APP-KO immunoblotting against the
N-terminus of APP result from cross reaction with the other APP family members
APLP1 and APLP2.
Mitochondrial dynamics are suggested to be crucial for Ca2+ homeostasis and local
energy supply [211]. Hence, investigation of mitochondrial morphology is providing
information about the network integrity of mitochondria and shedding light on mito-
chondria function.
Primary cultured astrocytes from WT and APP-KO animals were passaged twice,
fixed, and immunohistologically stained for the mitochondrial housekeeping protein
translocase of the outer mitochondrial membrane 20 (TOM20). The culture was
CT
y188100 
100
WT APPKO
NT
22c11
actin
actin
kDa
A B
Figure 2.10. Primary astrocytes harvested from APP-KO mice do not express APP. (A) Il-
lustration of primary astrocyte culture preparation from p3 pups of WT and APP-KO. (B) Western-
blot of primary astrocyte culture lysate from WT and APP-KO pups. Antibodies against C-terminus
(CT, Y188) and N-terminus (NT, 22c11) of APP confirm lack of APP in primary astrocytes from
APP-KO mice. The cytoskeleton protein β-actin serves as loading control.
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scanned for isolated, labelled astrocytes to image the mitochondrial network of a
single astrocyte with a confocal microscope (Figure 2.11A). The quantification of
mitochondrial morphology was based on the fluorescent signal of TOM20 that was
categorised in three different morphology classes depending on the pixel connectivity
(Figure 2.11B)[212]. Therefore, a threshold mask was generated with the programme
ImageJ and the ”Analyze Particles” function grouped the signal into puncta (0.1 -
2.7 μm), rods (2.8 - 8.8 μm) and network (from 8.9 μm). The morphology classes
were then normalised to the total TOM20 signal and displayed in percentage (Figure
2.11C). Mitochondria of APP-KO astrocytes displayed a more fragmented morphol-
ogy visualised by a reduction in network class (mean ± SEM in %: Wt = 87.96 ±
0.9643; APP-KO = 78.7 ± 1.351) but an increase in puncta (mean ± SEM in %: Wt
= 3.293 ± 0.319; APP-KO = 7.823 ± 0.592) and rod (mean ± SEM in %: Wt = 8.745
±0.6879; APP-KO = 13.47 ± 0.8753) morphology (Figure 2.11C).
In order to test if the lack in network type mitochondria does not derive from loss
of mitochondria, western blot analysis was performed: no change in mitochondrial
housekeeping protein content was detectable (Figure 2.11D)(mean ± SEM: WT = 1
± 0.07449; APP-KO = 1.096 ± 0.1026; p >0.05).
To ascribe the fragmented phenotype to the presence of APP, APP fused to eGFP
was reintroduced into a subset of APP-KO astrocytes via transient transfection. The
eGFP expression enabled suitable detection of APP-expressing astrocytes (Figure
2.11A). These astrocytes were also subjected to morphological characterisation based
on the TOM20 signal (Figure 2.11B) and displayed a mitochondrial morphology com-
parable to WT astrocytes (mean ± SEM in % APP rescue: network = 89.43 ± 1.542;
rods = 6.25 ± 0.9791; puncta = 4.321 ± 0.5902)(Figure 2.11C). Reintroduction of
APP into APP-KO astrocytes was able to restore the mitochondrial network.
The observed fragmented morphology of mitochondria in APP-KO astrocytes pro-
vides another hint that APP function sustains normal mitochondria network integrity
and that its depletion disrupts mitochondrial morphology and eventually function in
regulating Ca2+ homeostasis.
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Figure 2.11. APP-KO astrocytes display fragmented mitochondrial morphology that can
be rescued by reintroduction of APP. (A) Confocal images of immunofluorescently labelled mi-
tochondria stained with mitochondrial housekeeping protein TOM20 in WT, APP-KO and APP-KO
+ APP-GFP plasmid astrocytes. Scale bar = 10 μm. (B) Morphological classification of mito-
chondria into network, rods and puncta based on their TOM20 signal pixel integrity in astrocytes
of WT, APP-KO and APP-KO expressing APP-GFP plasmid. (C) Quantification of mitochon-
drial morphology classes of WT, APP-KO and APP-KO expressing APP-GFP plasmid. APP-KO
astrocytes have ∼ 10 % reduction in mitochondria network (One-way ANOVA, F(2,87) = 19.78, p
<0.0001), ∼ 5 % increase in rods (F(2,87) = 18.38, p <0.0001) and puncta (F(2,87) = 21.14, p
<0.0001) in comparison to WT, that can be rescued by expression of APP-GFP. ***p <0.0001, n
= 30. (D) Western blot of primary astrocyte culture reveals no changes in TOM20 level between
WT and APP-KO (two-tailed Students t-test, p = 0.4686, t(8); n = 5).
44
2.2 The role of APP in astrocytic function
2.2.3 Altered mitochondrial Ca2+ transients in APP-KO
astrocytes
To further link the observed fragmented phenotype to the functional Ca2+ alterations
oberserved in the intact tissue, astrocytic mitochondria were characterised in terms of
Ca2+ uptake behaviour. For this purpose, cultured primary astrocytes were transfected
with a plasmid encoding the Ca2+ indicator GCaMP6 together with a mitochondrial
targeting sequence (mitoGCaMP) (Figure 2.12A) under an astrocytic promotor [213].
Application of 100 μM ATP stimulates Ca2+ influx into astrocytes [213] via G-protein
coupled receptor (GPCR) on the cell surface. Mitochondria, in turn, take up the
cytosolic Ca2+ via mitochondrial Ca2+ uniporter (MCU). The elevated levels of mi-
tochondrial Ca2+ can be detected by increase in fluorescence of mitoGCaMP. Here,
two-photon microscopy was performed to image mitochondrial Ca2+ dynamics in as-
trocytes in response to stimulation. The image series was acquired with 1 Hz over 300 s
during which a 60 s baseline (Figure 2.12BI), an initial ATP response (Figure 2.12BII)
and the subsequent decay (Figure 2.12BIII) were imaged. A ROI encircling the en-
tire mitochondrial Ca2+ signal was drawn and traces of WT and APP-KO astrocytic
mitochondria (Figure 2.12C) were analysed in terms of response size and kinetics.
The baseline (Figure 2.12D)(mean ± SEM in a.u.: WT = 566.7 ± 222.4; APP-KO
= 378.8 ± 144.3; p >0.05) and amplitude (Figure 2.12E)(mean ± SEM in ∆F/F: WT
= 7.639 ± 2.049; APP-KO = 9.456 ± 3.295; p >0.05) of the stimulated mitochondrial
Ca2+ signal was not changed in APP-KO astrocytes. However, the kinetics of the
response was slower in APP-KO mitochondria, as they exhibited a longer rise time
(Figue 2.12F)(mean ± SEM in ms: WT = 9000 ± 2171; APP-KO = 16500 ± 2121; p
<0.05) and slower decay of the first (fast) slope (mean ± SEM tau (fast) in ms: WT
= 50791 ± 14985; APP-KO = 130670 ± 35905; p <0.05) but not the second slope
(mean ± SEM tau (slow) in ms: WT = 14184 ± 2629; APP-KO = 18679 ± 4975; p
>0.05) of the two-phase decay analysis (Figue 2.12G).
Next, the stimulation response amplitude ∆F/F was analysed depending on the
mitochondrial morphology. Thus, a ROI was positioned close to the nucleus where mi-
tochondria are arranged in the network conformation. Another ROI was placed close
to the edge of the cell where rod and puncta shaped mitochondria are located (Figure
2.13A). As the amplitude of the response differed considerably across astrocytic mi-
tochondria, a cell-intern ratio of ∆F/F network/edge ROI was formed and taken into
account for comparison between APP-KO and WT astrocytes. Ca2+ signals of APP-
KO mitochondria showed a significant decrease in the ∆F/F network/edge ratio in
comparison to WT (Figure 2.13B). The more detailed analysis of ∆F/F network/edge
ratio revealed spatially dependent alterations in APP-KO Ca2+ amplitude as a conse-
quence of either increased response of rod and puncta mitochondria or decreased Ca2+
signal in network-shaped mitochondria (mean ± SEM ∆F/F network/edge ratio: WT
= 2.691 ± 0.2324; APP-KO = 1.415 ± 0.3087; p <0.05)(Figure 2.13C).
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Figure 2.12. Stimulated mitochondrial Ca2+ signals of APP-KO astrocytes display slower
kinetics. (A) Confocal image of an astrocyte transfected with mitochondria-targeted GCaMP
(green, mitoGCaMP). Astrocytic cytoskeleton protein ezrin (red) confirms the cell identity. Scale
bar = 20 μm. (B) Illustration of the stimulation procedure (ATP) and region of interest (ROI)
encircling total mitochondrial Ca2+ signal (grey border). 1st picture: baseline, 2nd: peak ; 3rd:
decay. Scale bar = 20 μm. (C) Averaged mitochondrial Ca2+ traces in WT and APP-KO astrocytes
during 100 μM ATP application. (D) The baseline fluorescence (10 s before the peak)(Mann-
Whitney test, p = 0.6126; U = 23) and (E) the amplitude (p = 0.8665; U = 26) of the Ca2+
response of mitochondria in APP-KO astrocytes is not changed. (F) The rise time of Ca2+
traces of mitochondria is longer in APP-KO astrocytes, (p = 0.0129; U = 7). (G) The decay
of mitochondrial Ca2+ traces was divided into two phases: The 1st fast tau lasts longer in APP-
KO mitochondria (p = 0.0289; U = 9). The 2nd slow tau displayed no difference in APP-KO
mitochondria, (p = 0.3969; U = 20; n = 7-8).
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Figure 2.13. Stimulated mitochondrial Ca2+ signals of APP-KO astrocytes differ in distri-
bution within the mitochondria network. Analysis of ∆F/F network ∆F/F edge ROI ratio. (A)
Illustration of ROI position of network (magenta) and edge (green) in the astrocytic mitochondria.
(B) Example traces of network and edge traces of WT (top) and APP-KO (bottom) mitochondrial
Ca2+ traces. (C) Mitochondria from APP-KO astrocytes display a smaller ∆F/F network/edge
ratio (two-tailed Students t-test, p = 0.0067; t(13) = 3.223; n = 7-8 astrocytes.)
Examination of mitochondrial Ca2+ signal in APP-KO astrocytes revealed sub-
stantial differences in mitochondrial Ca2+ influx expressed by slower kinetics and
morphology-dependent uptake.
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2.2.4 Investigation of mitochondrial proteins in primary
astrocytes
In order to further understand the morphological and functional deficits of mitochon-
dria in APP-KO astrocytes, primary astrocyte cultures from APP-KO and WT pups
were lysed and employed for investigation of proteins involved in mitochondrial fis-
sion, Ca2+ transport and energy supply (Figure 2.14A,B). Cytochrome C is the pro-
ton pump of the respiratory chain in the inner membrane of mitochondria (Figure
2.14A). Increased levels of cytochrome C and its release from mitochondria are as-
sociated with a caspase mediated apoptotic mechanism [214]. The protein levels of
cytochrome C were significantly increased in APP-KO astrocytes when normalised to
cellular housekeeping protein (mean ± SEM: WT = 1 ± 0.03227; APP-KO = 1.989
± 0.3455; p <0.05) and mitochondrial housekeeping protein TOM20 (mean ± SEM:
WT = 1 ± 0.02545; APP-KO = 1.802 ± 0.3355; p <0.05)(Figure 2.14C). The ratio
phosphorylated dynamin related protein 1/dynamin related protein 1 (pDRP1/DRP1)
is a mitochondrial fission indicator [215]. The ratio of pDRP1/DRP1 was not changed
in APP-KO astrocytes (Figure 2.14D)(mean ± SEM: WT = 1 ± 0.07963; APP-KO
= 1.136 ± 0.121;p >0.05) suggesting that the fragmented mitochondrial morphology
in APP-KO might result from other aberrant proteins. The voltage dependent an-
ion channel (VDAC) and mitochondrial calicum uniporter (MCU) transports Ca2+
over the mitochondria membrane into mitochondria (Figure 2.14A) and are therefore
important for clearing Ca2+ from the cytosol [216]. The protein levels of MCU, nor-
malised to cellular (mean ± SEM: WT = 1 ± 0.09092; APP-KO = 1.208 ± 0.08404)
and mitochondrial housekeeping protein (mean ± SEM: WT = 1 ± 0.03245; APP-KO
= 1.133 ± 0.09828; p >0.05), were slightly but not significantly increased in APP-
KO astrocytes in comparison to WT (Figure 2.14B,E). TOM20 is part of the TOM
complex on the outer mitochondria membrane and serves as mitochondrial housekeep-
ing protein. The results of normalisation over TOM20 are similar to the results of
normalisation over cellular housekeeping protein calnexin (Figure 2.14C,E).
Mitochondrial protein levels of MCU and TOM20 and the ratio pDRP1/DRP1 are
not altered in the absence of APP suggesting that these proteins are not associated
with the mitochondrial phenotype in APP-KO. The elevated levels of cytochrome C
point towards malfunction and apoptosis which deserves further study.
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Figure 2.14. Investigation of mitochondrial proteins in primary astrocytes. (A) Illustrative
drawing of a mitochondrion and associated proteins. Cytochrome C (cyt c) is part of the respiratory
chain. DRP1 mediates outer mitochondrial membrane fission. MCU transports Ca2+ over the inner
membrane (IM) into the lumen. TOM20 is part of the TOM complex, transports proteins over
the outer membrane (OM), and serves as a mitochondrial housekeeping protein (hkprot). (B)
Western blots of primary astrocyte lysates of 3 × WT and APP-KO against DRP1, p-DRP1,
MCU, cyt c, TOM20, and cellular hkprot calnexin. (C-E) Western blot quantifications. (C) Cyt c
level is increased in APP-KO: Cyt c normalised to hkprot (left) (Students t-test: p = 0.0215 (*);
t(8) = 2.849) normalised to TOM20 (right) (p = 0.0443 (*); t(8) = 2.383). (D) Ratio of the
phosphorylated DRP1 (pDRP1)/DRP1 signal (p = 0.3764; t(8) = 0.9366) and (E) MCU levels
normalised to hkprot (left)(p = 0.1317; t(8) = 1.679) and to TOM20 (right)(p = 0.2351; t(8) =
1.284; n = 5) are not altered in APP-KO astrocytes.
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2.2.5 Isolation and protein investigation of astrocytes de-
rived from the adult mouse brain
For the investigation of cell specific molecule levels that resemble in vivo conditions,
astrocytes were acutely isolated from the intact adult mouse brain.
For this purpose, the mouse brain was quickly dissected after decapitation of the
mouse (Figure 2.15I). The cortex was isolated and chopped into small cubes that were
gently digested and homogenised with the GentleMACS with heaters machine (Figure
2.15II). Subsequently, the single cell solution was purified from cellular debris and red
blood cells before binding magnetic beads to astrocytes (Figure 2.15III). Next, the
cell solution was applied onto a column that was attached to a magnetic field. The
labelled astrocytes got stuck in the magnetic field while other unlabelled cell types
flushed trough the column. When the column was removed from the magnetic field,
the astrocytes were flushed out and collected in a separate falcon (Figure 2.15IV).
The yield of isolated astrocytes derived from the adult mouse brain was very little:
Cortices from 2 adult mouse brains result in ∼3 mio total astrocyte number account
for ∼60 μg protein lysate. The isolated astrocytes were either employed for astrocyte
culture confirming cell type identity and viability or for protein analysis via western
blotting (Figure 2.15V).
For cell culture, astrocytes were plated onto coated 6-well plates, one well con-
taining cortical astrocytes of one entire brain. After two days in vitro (DIV) some
astrocytes started to adhere on the dish and to form protrusions. After 9 DIV, the
cells spread out to a size larger than 100 μm. Staining against astrocytic markers such
as s100β, GFAP and ezrin confirmed the identity of astrocytes (Figure 2.16A).
Moreover, isolated astrocytes derived from the adult brain were lysed for subse-
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Figure 2.15. Isolation of astrocytes derived from the adult mouse brain. Procedure of
astrocyte isolation from brains of 6 months old mice. (I) The brain is quickly harvested from the
mouse and the cortex is dissected. (II) Cortical brain tissue is incubated and homogenised in the
GentleMACS machine. (III) Antibodies coupled to magnetic beads are added to cell homogenate
and bind to astrocytes. (IV) Cell homogenate with magnetic beads bound to astrocytes is applied
onto a column attached to a magnetic field. Astrocytes stay in the magnetic field while other cell
types are flushed through the column. Then, the column is removed from the magnetic field and
astrocytes are collected. (V) Isolated astrocytes are either used for growing in a cell culture dish
or lysed and further employed for protein analysis by western blot.
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quent western blot analysis. Due to the small yield of the isolation, the cortices of two
animals were taken for one replicate. The westen blot analysis confirmed the lack of
APP in astrocytes isolated from the adult cortex and hippocampus by immunoblot-
ting against APP CT and APP NT (Figure 2.16B,D). Furthermore, blotting against
GFAP indicated astrocytic identity of the lysate (Figure 2.16B). As cytochrome C
levels were increased and MCU seemed slightly elevated in primary astrocyte cultures
from APP-KO pups, the results are comparable to astrocytes derived from the adult
brain: Indeed, adult astrocytes displayed slightly increased levels of MCU (mean ±
SEM in a.u.: WT = 4212 ± 716.4; APP-KO = 5225 ± 455.3; p >0.05) and cy-
tochrome C (mean ± SEM in a.u.: WT = 4446 ± 673.7; APP-KO = 4649 ± 1327; p
>0.05)(Figure 2.16B,C). The statistical test was a paired t-test, as samples differed a
lot between biological replicates. Hence, protein concentrations were compared over
the same preparation procedure of the same day.
Isolation of astrocytes from the adult brain is a suitable tool for the investigation
of astrocytes that matured in the intact brain. However, the small yield requires large
amounts of tissue, respectively.
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Figure 2.16. Characterisation of astrocytes isolated from the adult brain and investigation
of mitochondrial proteins. (A) Immunohistochemical analysis of astrocytes isolated from the
adult brain and grown in a cell culture dish for 9 days after isolation proves astrocytic identity:
Staining against s100β and DAPI (left); glial fibrillary acidic protein (GFAP) and DAPI (middle);
ezrin and DAPI (right). Scale bar = 100 μm. (B) Western blots of lysates from astrocytes of adult
cortices from WT and APP-KO mice (two animals each). Antibodies against APP CT and APP
NT proof the lack of APP in isolated cortical astrocytes from APP-KO mice. Antibody against
GFAP verifies astrocytic identity. Calnexin serves as housekeeping protein. (C) Quantification of
MCU and cyt c signal paired over one preparation day (grey connecting line between data points)
does not reveal significant differences between WT and APP-KO astrocytes (paired Students t-test,
MCU: p = 0.0795, t(2) = 3.33; n = 3. cyt c: p = 0.8185, t(2) = 2.61 ; n = 3). (D) Antibodies
against APP CT and APP NT prove the lack of APP in astrocytes isolated from the hippocampus
of APP-KO mice.
52
Chapter 3
Discussion
53
3. Discussion
3.1 The role of APP in synaptic plasticity in
the cortex and hippocampus
The pathology of AD is characterised by the excessive abundance of the Aβ peptide
that aggregates and forms extracellular amyloid plaques [19],[76] and intracellular
neurofibrillar tangles [217]. The amyloid-cascade hypothesis states that accumulation
of Aβ is the central step in the etiology of the disease [33],[218] whereupon soluble
oligomeric Aβ is suggested to be the harmful factor causing synaptic and cognitive
deficits [36].
The amyloid precursor protein (APP) is crucially involved in the generation of
the pathology of AD, as Aβ is the proteolytic cleavage product of APP [35]. Current
therapeutic strategies aim to decrease Aβ production by targeting APP cleavage, for
instance via BACE1 inhibition. This interference with levels of APP and its cleavage
products demands understanding of the role of APP in the brain.
APP has been shown to be important for many brain functions [64]. So far, the role
of APP has been mainly investigated in neurons. However, there is emerging evidence
that complex brain functions derive from the interplay of neuronal and astrocytic
activity [144]. Astrocytes play an active role in regulating brain networks by refining
synapses, clearing the extracellular space and modulating trafficking of neuro- and
gliotransmitters [153],[144].
Therefore, understanding the physiological function and subcellular action sites of
APP in astrocytes is crucial for shedding light on basic physiological brain function
and on AD related aspects.
3.1.1 Lack of APP does not result in altered NMDA/AMPA
receptor currents
In vivo imaging of dendritic spines in the cortex of APP-KO animals revealed impaired
neuronal plasticity that was manifested by reduced spine turnover and reduced thin
spines. When neuronal plasticity was stimulated by placing the animals into enriched
environment, WT animals diplayed increased spine density while the spine density in
APP-KO animals remained unchanged. These observations came along with decreased
extracellular levels of the gliotransmitter D-serine which in turn could rescue the spine
plasticity deficits when orally applied to the animals. Together, APP maintains spine
plasticity via D-serine [96] and this raised the question whether NMDAR density
is reduced in APP-KO animals, as D-serine potentiates as a endogenous co-agonist
NMDAR [219]. As the presence of NMDAR is associated with spine stability and
certain spine types [202], reduced NMDAR density might be a potential consequence
of reduced extracellular D-serine levels and decreased thin spines. Moreover, APP has
been shown to regulate NMDAR levels at the postsynapse [220],[92],[221].
To approximate the density of NMDAR, patch clamp recording of stimulated NM-
DAR and AMPAR currents were performed in neurons of cortical layer V. The ap-
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proach revealed no difference in the NMDA/AMPA receptor current ratio between
APP-KO and WT mice suggesting no changes in the receptor composition due to
the lack of APP. Paired-pulse fascilitation recordings additionally showed unaffected
presynaptic transmission despite the lack of APP. These findings suggest that the
effect on spine plasticity might derive from a different source or region.
APP has been shown to enhance synaptic activity, synapse formation, and den-
dritic spine formation [94]. In cell culture, enhanced NMDAR currents and NR2B-
containing receptors on the postsynaptic membrane were linked to overexpression of
APP [221] while APP 695 was associated with increased NMDAR subunits NR2A and
NR2B to the surface [92]. In contrast, autaptic hippocampal neurons lacking APP
display enhanced amplitudes of evoked AMPAR- and NMDAR-mediated EPSCs, in-
creased mEPSC frequency and more vesicles in their readily release pool [95].
In the intact brain, APP AICD has been shown to regulate GluN2B levels that
are associated with immature excitatory synapses [220]. Accordingly, it would not
be surprising, if lack of APP results in reduced NMDAR on the cell surface and
therefore reduced currents. The reduced NMDAR currents would result in a shift
of NMDA/AMPA receptor ratio, assuming unchanged AMPAR density. However,
changed protein levels of postsynaptic NMDAR in APP-KO have never been reported
probably also because isolation of postsynapses from brains is challenging.
Additionally, APP-deficient mice show decreased glutamate levels and increased
GABA levels, in addition to upregulated GluR2 subunit of AMPAR [206]. Both are
hints that APP plays a role in excitatory synaptic transmission. The observed un-
changed NMDA/AMPA ratio in the cortex of APP-KO animals from the present
study does not exclude parallel changes of both NMDAR and AMPAR levels. How-
ever, basic synaptic transmission is reported to be not changed in APP-KO animals
[64].
As the APP family members APLP1 and APLP2 are also associated with increased
levels of NMDAR subunits on the cell surface [93], a compensatory mechanism could
explain the unchanged NMDA/AMPA receptor ratio in the absence of APP.
As APPsα has been shown to facilitate NMDAR currents both ex vivo and in
vivo in the hippocampus [203], lack of APP could also result in decreased NMDA
currents, as its cleavage product APPsα cannot be generated from APLP1 and APLP2.
Hence, the recorded NMDA/AMPA current ratio is independent of APPsα or other
parameters compensate the lack of the neurotrophic factor APPsα.
Morover, a difference in morphological distribution of dendritic spines was reported
between WT and APP-KO (less thin, more mushroom spines in APP-KO) [96]. As
morphology of spines is associated with plasticity and activity [202], a change of re-
ceptor density would not be surprising. Still, the investigated spines in the cortical
layer I are not the synaptic input from the recorded NMDA/AMPA receptor currents,
as the stimulation electrode was placed around layer III while positioning it in layer
I would have been technically cumbersome and would be subject to the space clamp
problem [222]. The space clamp problem means that controlled voltage at the soma
with the voltage clamp only partially controls the membrane voltage distant from the
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soma. Hence, one cannot exclude different postsynaptic constitution along the entire
cortical layer V neurons.
The experiment decribes no differences in the NMDA/AMPA receptor current
ratio. Thus, the morphological changes in spine plasticity in the cortex of APP-
KO animals cannot be related to alterations in the postsynaptic excitatory receptor
composition. However, selective protein investigations of the postsynaptic membrane
would further elucidate, if there is an alteration in the receptor density or if the
spine plasticity alterations might derive from a different synaptic component such as
astrocytes.
3.1.2 Reduced LTP in APP-KO animals cannot be res-
cued by D-serine application
Long-term potentiation (LTP) is a long-lasting strengthening of synaptic transmission
that is considered to be the underlying mechanism of learning and memory [131].
LTP depends on the presence of extracellular D-serine which is released in a Ca2+
dependent manner from astrocytes [159]. As APP-KO animals have been shown to
display decreased extracellular D-serine levels [96] and reduced LTP in old animals
[223],[224],[205],[101], a potential rescue of the reduced LTP was tested by D-serine
application. Firstly, the reduction of LTP was shown in young adult mice. The acute
and chronic application of D-serine, in the recording bath containing the brain slice
and orally to the animal, failed to rescue the reduced LTP. This result clearly shows
that D-serine alone is not capable to rescue the reduced LTP in APP-KO animals.
Previous studies show that bath application of D-serine rescues LTP in an astro-
cytic Ca2+ dependent manner [167],[159]. As mentioned, APP plays a fundamental
role in the homeostasis of D-serine in the cortex thereby being important for spine plas-
ticity [96]. As the simple application of D-serine to APP-KO animals and brain slices
does not rescue the reduction of LTP in the hippocampus, the plasticity impairment
in the hippocampus of APP-KO animals is supposedly more complex.
For instance, the presence of APP cleavage products could be important for hip-
pocampal plasticity. Accordingly, the absence of the cleavage product APPsα could
have an impact, as it has been shown to positively influence NMDAR current, LTP
and spatial memory [203] and rescue abnormalities in behaviour and LTP of APP-
KO mice [101]. APPsα promotoes NMDAR level increase by increased recruitment of
NMDAR to the postsynaptic site [100],[92]. Additionally, APPsα has been shown to
facilitate NMDAR currents both ex vivo and in vivo in the hippocampus [203] which
would not be detectable by I/O and paired-pulse recordings (solely AMPAR currents).
Hence, the reduction in LTP might be caused by NMDAR impairment in the absence
of APPsα. Moreover, physiological levels of Aβ were shown to potentiate LTP [98],
while another cleavage product such as Aη has opposite effects on hippocampal LTP
[225]. Both peptides are also absent in APP-KO animals.
The reduction in LTP in young adult mice is not in line with previous studies in
which decreased LTP was only described in old (13 months) but not in young APP-
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KO animals [205],[223],[224],[101]. However, in these studies the LTP was elicited
with a different (tetanic) stimulation protocol potentially explaining the differences
in the experimental outcomes. Surprisingly, D-serine application on WT slices in the
recording chamber resulted in a LTP that was not significantly different to LTP in
APP-KO. A previous study reports no change of LTP after D-serine bath application
to the WT [167] which could again derive from a different stimulation protocol. In the
present study 1 × 1 s trains of 100 Hz stimulation was applied, while Shigetomi and
colleagues [167] used 2 × 1 s trains of 100 Hz stimulation with intertrain interval of
10 s.
APP is suggested to be involved in glutamate synthesis, as APP-KO mice displayed
a decreased pool size of glutamate, while the pool was increased by APP overexpression
[206]. Decreased glutamate could explain the decreased LTP and also ineffectiveness of
D-serine application. However, the I/O and paired pulse facilitation were not affected
in APP-KO which excepts altered glutamate release in basic synaptic transmission.
Noteably, the I/O and paired-pulse facilitation at all tested intervals were also shown to
be unchanged between aged APP-KO and WT [223],[224],[226] in accordance with the
observations in this study in young adult mice. Hence, a basic synaptic transmission
deficit can be excluded in the hippocampus of APP-KO and the defect is consequently
plasticity related.
It is known that astrocytes are highly involved in synaptic plasticity. Especially,
increased astrocyte-synapse interactions have been reported during LTP induced by
theta-burst stimulation [150]. Thereby, astrocytes respond to increased neuronal ac-
tivity by changing their morphology to promote astrocytic synapse coverage. This
process requires glutamate release from the presynapse and receptors on the astro-
cytic membrane and intracellular elevations of Ca2+ in the astrocyte, respectively
[150]. The reduction of LTP in the hippocampus of APP-KO brains might also re-
sult from an activity dependent imbalance of glutamate release and uptake within the
tripartite synapse, also suggested for AD [227]. The imbalance of glutamate release
would be confined to plasticity related activity, e.g. after tetanic stimulation, as the
AMPAR-related stimulation/response (I/O) curve was not changed between WT and
APP-KO. The unchanged I/O also implies no change in AMPAR density.
To sum up, reduced LTP was also observed in young adult APP-KO animals.
Application of the gliotransmitter D-serine, which rescued spine plasticity deficits in
the cortex of these animals, failed to rescue LTP in the hippocampus. The reason for
that could be an array of possibilties including decreased NMDAR density, aberrant
glutamate levels, and altered astrocytic involvement.
In a prospective study, in vivo investigations of spine plasticity via a hippocampal
window and plasticity stimulation via hippocampus-related learning tasks would shed
light on the role of APP in hippocampal structural plasticity. Moreover, examination
of NMDA receptor density and D-serine levels in the APP-KO hippocampus would
help to understand the cause of reduced LTP in APP-KO mice.
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3.1.3 Astrocytic APP impacts spine density and mor-
phology in the cortex and hippocampus
Dendritic spine plasticity and morphology are closely related to synaptic function.
For instance, structural remodeling of dendrites is a learning dependent process [124].
Moreover, the stability of dendritic spines is important for accurate brain function and
destabilisation is associated with psychiatric or neurodegeneative diseases [123].
In order to investigate the role of astrocytic APP on excitatory synapse density
and composition in the cortex and hippocampus, a confocal ex vivo investigation of
dendritic spine density and morphology after conditional knock-out of APP (cAPP-
KO) in a subset of adjacent astrocytes was performed. Intriguingly, the changes in
dendrite appearance differed among the distinct brain areas. cAPP-KO in cortical
astrocytes did not change the total spine density in adjacent WT neurons. But,
the number of thin spines was reduced that are considered to be more plastic and
transient [202]. This is in line with the in vivo observation of constitutive APP-KO
animals that lack APP in neurons and astrocytes [96]. Consequently, the less transient
spine composition observed in the cortex might be due to lack of astrocytic APP, as
it can be detected in both cAPP-KO in astrocytes and constitutive KO (neuronal
and astrocytic)[96]. In contrast, increased spine density in the cortex of APP-KO
was reported in an in vivo approach in which spines of any morphological type were
increased in number [97].
In contrast to the cortex, selective cAPP-KO in the hippocampus of adult mice re-
sulted in increased dendritic spine density. Both dendrites of the stratum oriens (basal)
and stratum radiatum (apical) displayed increased number of mushroom spines. Note-
worthy, mushroom spines are considered to be more stable postsynapses, important
for learning [202].
In in vitro studies, loss of APP in neurons was shown to reduce spine density in
cultured hippocampal neurons and in vivo in CA1 region of 13-months old but not
in young animals [205]. In line with this, another study on cultured hippocampal
neurons showed that overexpression of APP resulted in increased spine number, while
knockdown of APP reduced spine density [206]. An additional study showed that hip-
pocampal neurons from APP-KO mice in vitro display reduced viability and impaired
neurite development [91]. Moreover, the astrocytic role of APP was investigated by
co-culturing WT neurons with APP-KO astrocytes. The neurons co-cultured with
APP-KO astrocytes displayed decreased branching and length than those co-cultured
with WT astrocytes [91]. In order to relate these studies to the findings of this thesis,
cAPP-KO in astrocytes of the intact brain might elicit a compensatory effect by which
neurons increase spine density and change spine morphology. The cell culture exper-
iments are not applicable to in vivo conditions because neurons were either isolately
investigated or in terms of neuron-astrocyte coculture astrocytes which is entirely
isolated from the physiological brain environment.
The cell-adhesion function of APP can connect synaptic components and thereby
play an important role in the stability of synapses [228],[229]. This feature can explain
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the spine-promoting effect in APP overexpressing neurons which depends on the E1
extracellular domain of APP [206]. It is reasonable to assume that reduced interaction
of astrocytes with dendritic spines results from disrupted cell adhesion when APP
is lacking in one interaction partner. Additionally, this might result in decreased
glio-neuron communication and decreased potentiation of neuronal synapses, e.g. via
gliotransmitters such as D-serine, to which the neurons react by forming more stable
excitatory synapses that are observable by more mushroom spines in the hippocampus.
In contrast, the neurons of the cortex respond differently, as they decrease the fraction
of transient thin spines without change in overall spine number.
Investigations of the neuropil in the hippocampus have shown that thin spines are
covered more by astrocytes than larger spines [154] and the spine morphology also
determines NMDAR density and Ca2+ influx into the spine and the dendritic com-
partment [230]. Hence in the cortex, neurons have less thin spines because astrocytes
might retract from the synapse affecting mostly thin spines. On the contrary, neurons
from the hippocampus behave differently. Potentially, different expression levels of
APP depending on the brain region and different compensatory mechanism respond
to the lack of APP, respectively.
In the hippocampus, lack of astrocytic APP could lead to elevated neuronal ac-
tivity by increasing and reshaping dendritic spines, in particular mushroom spines
which, because of their large head surface, can generate stronger postsynaptic signals
[125],[126]. This could be a compensatory mechanism as a response to loose proximity
of astrocytic protrusions that usually supports synaptic function [144] when APP acts
as an cell adhesion molecule [228],[229].
It remains elusive why lack of astrocytic APP results in distinct phenotypes in
different brain regions. This discrepancy might be caused by different protein ex-
pression levels in distinct brain regions [231] and in different astrocyte populations
[232],[233]. Thus, the impact of APP-KO absence and thus the role of APP might
differ accordingly.
It has been shown that astrocytes express glutamate transporters at different lev-
els in distinct brain areas during development and adulthood [234],[235]. Hence, these
region-specific differences in protein expression in astrocytes might lead to diverse phe-
notypes in the absence of APP [236]. For instance, GFAP expression in astrocytes of
the hippocampus and cortex is described as diverse. While almost all hippocampal
astrocytes express GFAP, only astrocytes of the upper and lower layers of the cortex
express GFAP [233]. Even within one brain area such as the hippocampus, a het-
erogeneity is suggested among GFAP positive astrocytes that might participate in or
differently modulate glutamate synaptic transmission [237].
In the present approach, the expression of Cre recombinase was depending on
GFAP promotor activation in astrocytes. The fluorescent protein expression confirms
the presence of active Cre recombinase and thus potential KO of APP. A proof of KO
is missing in the experimental design. However, it is very difficult to immunohistolog-
ically confirm KO of APP and particularly in the ramified processes of astrocytes in
50 μm thick brain slices. KO of APP in astrocytes resulted in changed density and
59
3. Discussion
morphology of dendritic spines suggesting a crucial role of APP in astrocytes in CA1
of the hippocampus and even assign a function in terms of synaptic integrity.
A further experiment linking astrocytic APP to excitatory synapse integrity would
be the treatment of astrocytic conditional KO animals with the gliotransmitter D-
Serine [238] that has been shown to compensate the deficits in dendritic spine plasticity
in the cortex of constitutive APP-KO mice [96]. Moreover, generation of a global con-
ditional KO of astrocytic APP would allow approaches such as chronic spine imaging
in vivo in the cortex and hippocampus, D-serine level measurements, astrocytic Ca2+
imaging, behaviour tests and LTP recordings in the acute slice. This would further
elucidate the role of astrocytic APP in the adult brain.
3.1.4 Conclusion I
Without doubt, the function of APP at synapses and adjacent astrocytes is puzzling
and quite likely not uniform across neurons, astrocytes and brain regions. While in the
cortex of APP-KO animals the reduced spine plasticity could not be linked to altered
levels of excitatory receptor composition (NMDA/AMPA), it could be rescued by ap-
plication of the gliotransmitter D-serine. Hippocampal LTP is reduced in APP-KO
animals but cannot be rescued by D-serine application suggesting additional mecha-
nisms important for synaptic plasticity that lack in the hippocampus in the absence
of APP.
Selective and conditional KO of APP in a subset of astrocytes within the cortex and
hippocampus resulted in brain region specific alterations of dendritic spine morphology
and density in the adjacent neuron. Decreased thin spines whithout effects on the
spine number were observed in the cortex, while hippocampal dendrites displayed
increased spine density due to increased fraction of mushroom spines. The brain region
specific consequences of astrocytic APP-KO on dendritic spines might be attributed
to different astrocytic subpopulations and thus, receptor composition.
These findings accentuate not only the role of astrocytes in synaptic plasticity
and integrity but also clearly assign a crucial physiological function to APP for the
tripartite synapse that differs across brain regions.
3.2 The role of APP in astrocytic function
Astrocytes are highly involved in synaptic plasticity [150] that is aberrant in the ab-
sence of APP. In particular, KO of APP affects structural plasticity in neurons linked
to decreased levels of gliotransmitter D-serine [96]. Hence, the role of APP was further
investigated in astrocytes.
To decipher the role of APP in astrocytic function, Ca2+ transients in astrocytes
were investigated, as Ca2+ is implicated in a variety of cellular processes. For instance,
intracellular Ca2+ promotes gliotransmitter release important for the modulation of
neuronal function [238]. More specifically, interference with Ca2+ signals in astrocytes
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has been shown to reduce D-serine release with consequences on synaptic plasticity
such as LTP [167],[159].
As previous studies described alterations in Ca2+ signalling and homeostasis in
astrocytes that lack APP [110],[112], the role of APP in terms of astrocytic Ca2+
activity was deeper investigated within the course of this study.
3.2.1 APP plays a role in perisynaptic Ca2+ signalling in
astrocytes
To understand the role of APP in astrocytic function during basal activity in the
brain, spontaneous intracellular Ca2+ transients were investigated in astrocytes of the
hippocampus and cortex in acute brain slices of WT and APP-KO animals. More
specifically, the Ca2+ transients in small astrocytic protrusions were assessed, as they
form the contact sites to synapses participating in neuronal signalling.
Astrocytic expression of a membrane-tethered Ca2+ indicator [194] allowed to de-
tect alterations of Ca2+ transients in the hippocampus and cortex of APP-KO animals.
The analysis of spontaneous Ca2+ activity within the ramified processes of astrocytes
involves an elaborate protocol that filters the background noise and detects active ar-
eas that display changes in fluorescence. These active areas are termed microdomains
[239] and act as ROI for Ca2+ trace extraction from the raw image sequence.
In the cortex of APP-KO animals, the number and size of active microdomains was
not changed indicating no alterations in the composition of active sites within the pro-
trusions of APP-KO astrocytes during spontaneous activity. However, the frequency
(evt/min/domain) of Ca2+ transients within the microdomains was significantly re-
duced in APP-KO. These findings suggest that the lack of APP does not result in a
spatial restriction of active microdomains but rather locally confined decreased Ca2+
activity potentially resulting in insufficient synaptic support. The amplitude and area
under the curve of the astrocytic Ca2+ events were not changed, indicating that the
amount of Ca2+ within one event is not altered despite the lack of APP. Furthermore,
the rise time of astrocytic Ca2+ transients is longer in APP-KO in comparison to WT
denoting a latency in reaching the Ca2+ transient peak. This latency shows prolonged
increase of intracellular Ca2+ that might be due to delayed release of Ca2+ from intra-
cellular stores. In contrast, the transient decay time remained unaffected proposing
no alterations in the clearance of Ca2+ from the cytosol.
In the hippocampus of APP-KO animals spontaneous astrocytic Ca2+ activity
exhibits different features in comparison to the cortex. While the number of active
microdomains was unaltered, APP-KO animals displayed increased size in their active
microdomains in the astrocytes of the hippocampus. The frequency of Ca2+ events
was also reduced in hippocampus of APP-KO mice. Hence, the active microdomains
of APP-KO astrocytes are larger and less active. This result suggests a spatial ex-
pansion of Ca2+ signals within astrocytic protrusions with less frequent emergence.
The amplitude, rise and decay time and the area under the curve of the Ca2+ events
remained unchanged in APP-KO suggesting no differences in the release, uptake and
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amount of intracellular Ca2+ events.
It is important to understand the local function of astrocytic microdomains in
order to evaluate the contribution of APP to the communication between astrocytes
and neurons [144].
Astrocytes have been shown to display structural plasticity depending on neuronal
activity [150]. Since APP acts as an cell-adhesion molecule [228],[229], the lack of APP
might disrupt the close proximity of synapses and astrocytic protrusions, resulting
in altered communication. Consequently, APP-KO astrocytes might not be able to
be adequately sensitive to adjacent neuronal activity e.g. via transmitters in the
extracellular space which might result in decreased Ca2+ signalling and gliotransmitter
release.
Additionally, NMDAR and AMPAR on the surface of astrocytes modulate astro-
cytic currents [240],[241]. As APP cleavage products interfere with these receptors
[64], the lack of APP and its cleavage products might also influence astrocytic Ca2+
transients via these glutamate receptors. The aforementioned heterogeneity of astro-
cytes across the brain and in brain regions [236] can also explain the differences in
microdomain size and kinetics that were observed between cortex and hippocampal
GFAP positive astrocytes. The heterogeneity in neocortical astrocytes is exemplified
by layer-specific morphological, molecular and Ca2+ activity differences [242],[243].
Astrocytes are electrically coupled via gap junctions that are important for the
propagations of Ca2+ signals. The major gap junction component in astrocytes is
connexin 43 which has been shown to be downregulated in vitro when the intracellular
domain of APP was missing [244] or elevated levels of connexin 43 were found in
AD mouse models associated with increased amounts of Aβ [245],[246]. Hence, APP
might be crucial for physiological composition of gap junctions and thus adequate
inter-astrocyte communication.
APP has been shown to be crucial for intracellular Ca2+ homeostasis in cultured
astrocytes [110],[112] suggesting interactions of APP with the endoplasmic reticulum
and mitochondria that are involved in intracellular Ca2+ homeostasis. Moreover, APP
localises at these organelles where it fulfills different functions [106],[69],[247],[107].
In acute slices, astrocytes exhibit intrinsic signalling independently of neuronal
activity [248]. In contrast, in the experiments of the present study neuronal activity
was not blocked by any specific blockers. Hence, the neurons were spontaneously active
within the brain network of the acute brain slice. Consequently, it cannot be concluded
that the observed frequency alterations of astrocytic Ca2+ transient in APP-KO are
purely due to intrinsic astrocytic activity or an interplay of spontaneous neuronal
and astrocytic activity. However, no changes in basal neuronal network activity have
been reported in APP-KO [64],[249]. Investigations in the stratum radiatum of the
hippocampus in acute slice showed that astrocytic Ca2+ signals can derive in the
absence of neuronal activity and extracellular Ca2+ implicating a crucial contribution
of Ca2+ from intracellular stores to Ca2+ signalling [250]. Moreover, this study showed
that increased amounts of Aβ (100 nM) lead to increased Ca2+ event frequency [250].
However, these approaches were not conducted in the ramified processes but in the
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main branches of astrocytes. But still, physiological levels of Aβ might positively
effect the reduced frequency in APP-KO animals, similar to physiological levels of Aβ
(picomolar range) positively impact reduced LTP in APP-KO hippocampus [98]. This
could easily be tested by incubating the brain slice in Aβ containing ACSF prior to
astrocytic Ca2+ recordings.
The Ca2+ source within astrocytes differ depending on the localisation. Hence, it
has been shown that KO of Ip3r2 in the ER results in lack of somatic Ca2+ signalling
in astrocytes. In contrast, the Ca2+ signals within the fine processes of astrocytes were
not abolished [251]. Generally, majority of Ca2+ transients have been shown to occur
in astrocytic processes and not in the soma [251]. Within these processes mitochondria
are crucially involved in the generation of local Ca2+ transients [211],[195],[252].
Another study showed that spontaneous and evoked astrocyte Ca2+ signalling in
the mossy fiber terminals of the hippocampus is tightly regulated by glutamate and
even more specifically by glutamate uptake via glutamate transporters (GLT-1 and
GLAST) [253]. Moreover, mitochondrial positioning within astrocytic microdomains
appeared to be close to glutamate transporters and related to neuronal activity [254].
This suggests to investigate the extracellular glutamate levels in APP-KO animals in
order to understand whether APP is crucially influencing glutamate in any aspect.
It is clear that experimental manipulation of astrocytic Ca2+ is not a straightfor-
ward practice and can produce different results depending on approach and context
[165]. As astrocytic Ca2+ imaging in the hippocampal slice has been proven to be a
suitable tool, a future approach could be the investigation of astrocytic Ca2+ tran-
sients during the induction of LTP and afterwards. This could shed light on the role
of APP on astrocytic function during synaptic plasticity. This can be related to glu-
tamate release and/or uptake by the astrocytes, as the present study has proven that
the LTP deficit is not rescuable by D-serine application.
The close proximity of astrocytes and neurons in APP-KO animals and animals
with conditional astrocytic KO of APP could be investigated by a recently developed
method allowing the measurement of neuron - astrocyte proximity via Fo¨rster reso-
nance energy transfer (FRET) between astrocyte processes and presynaptic terminals
[255]. This technique could be applied in vivo during behaviour and in the acute brain
slice during LTP recordings and could answer the question whether APP-KO animals
have a neuron-astrocyte proximity problem during plasticity that could be respon-
sible for the deficit. One could further speculate whether this might be due to the
cell-adhesion function. Even further, the reduced proximity could result in defective
neuron-glia communication such as the reduced D-serine release/levels [96].
In a broader sense, a function in astrocytic Ca2+ signalling can be attributed to
APP, as the frequency of astrocytic Ca2+ transients were reduced in both cortex and
CA1 of the hippocampus. Interestingly, there are region-specific differences in astro-
cytic Ca2+ signalling as consequences of APP-KO between hippocampus and cortex:
microdomain size enlarged in APP-KO hippocampus and rise time prolonged in APP-
KO cortex. These differences across brain regions could result from a heterogenity of
astrocytes.
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3.2.2 APP is crucial for mitochondrial network integrity
The Ca2+ transient along the fine processes of astrocytes are defined by mitochondria
mediated ion homeostasis [195],[210]. As aberrations of Ca2+ transients in delicate
protrusions of astrocytes were detected, the question was raised whether the absence
of APP directly affects mitochondrial integrity. Indeed, fragmented mitochondria have
been observed in primary APP-KO astrocyte cultures. Convincingly, this phenotype
could be rescued to WT level by reintroduction of APP.
Mitochondria morphology is very divers and dynamic [256]. Mitochondrial fusion
and fission events in astrocytes are getting imbalanced in the incidence of injury or
pro-inflammatory stimuli in acute slices [257]. Here, it can be assumed that APP-KO
astrocytes are in a constant state of inflammation, which could explain the fragmented
mitochondrial morphology. In support of this hypothesis, APP-KO mice have been
described to develop reactive gliosis [89].
Mutations in the C-terminus region of KPI-APPs caused decreased localisation
of APP to mitochondria together with mitochondrial fragmentation and dysfunction
in HeLa cells [115]. Thereby, KPI-APPs harbour a mitochondrial localisation signal
that is important for localisation of APP to mitochondria and mitochondria function.
Overexpression of WT APP and APP harbourig the swedish mutation leads to mito-
chondrial fragmentation resulting from imbalanced fission/fusion which is suggested
to drive mitochondrial and cellular dysfunction [109]. Based on the findings that ei-
ther missing mitochondrial localisation [115] or overproduction of APP [109] or full
APP-KO in astrocytes exhibit a fragmented phenotype of mitochondria, at this point
the conclusion can be drawn that a physiological level of APP in the cell is important
for mitochondrial integrity. This is in line with the findings of this study in which
reintroduction of APP via expression by the EF1α promoter resulted in a rescued
mitochondrial morphology in APP-KO astrocytes.
AD has been linked to malfunction of mitochondria [258],[259], as structurally and
functionally aberrant mitochondria have been found in AD [260],[114] and in neurons
of animal models of AD [261],[262]. Even though these studies are confined to neurons,
also mitochondria of astrocytes could be highly affected in AD which in turn influences
local energy demands and Ca2+ buffering important for synaptic support.
Recent findings in AD research delineate mitochondria dysfunction which is closely
associated with phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1)
signalling [263]. PINK1 was reported to be implicated in mitofusin ubiquitination
important for mitophagy [264]. It has been shown that the modulation of AICD levels
or γ-secretase activity affects PINK1related control of mitophagy and mitochondrial
dynamics [265]. Hence, APP-KO astrocytes might display altered mitophagy and
mitochondrial dynamics due to missing interaction of PINK1 and AICD. Therefore,
reintroduction of AICD alone would be a potential approach for targeting this question.
The fragmented mitochondria might be one reason why intracellular Ca2+ is aber-
rant in the protrusions of APP-KO astrocytes in the acute brain slice. Consequences
are the altered release of transmitters such as D-serine [96],[238] and potentially also
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glutamate [174].
A future experiment could be a morphological investigation of mitochondria in
astrocytes within the intact brain by expressing mitochondrial marker [257]. This
would further elucidate whether APP-KO leads to mitochondrial abnormalities within
astrocytes that are actively participating in the cellular network, for instance during
glutamate take up and appropriate localisation of mitochondia [254].
3.2.3 Mitochondrial Ca2+ imaging in primary astrocytes
The lack of APP results in alterations of astrocytic microdomain Ca2+ transients
which depend on mitochondria function and localisation [195],[211]. As mitochondria
of APP-KO astrocytes displayed a fragmented phenotype, the function in terms of
Ca2+ uptake was further tested. Therefore, stimulated Ca2+ elevations within the
mitochondria of cortical astrocytes were visualised by mito-GCAMP and triggered by
bath applications of GPCR agonist ATP. The elevations in the mitochondrial Ca2+
levels originated from the influx of Ca2+ through the mitochondrial uniporter (MCU).
Primary APP-KO astrocytes displayed slower kinetics of mitochondrial Ca2+ sig-
nals but unchanged amplitude (∆F/F) when the entire mitochondrial Ca2+ signal was
taken into account. Moreover, the lack of APP does not change the basic Ca2+ level
in astrocytes, as no change was observed in the basal Ca2+ signal in mitochondria.
These findings are in line with a study that describes unchanged basal Ca2+ levels
in the cytosol of APP-KO astrocytes [112]. The observed prolonged kinetics might
derive from insufficent clearing of Ca2+ from the intracellular space by mitochondria,
but can also come from slower Ca2+ release from the ER. APP fragment C99 has been
shown to be localised at the ER-mitochondria contact site [106]. Consequently, the
lack of APP might impair the proximity of ER and mitochondria resulting in altered
Ca2+ signalling.
The more detailed analysis of ∆F/F network/edge ratio revealed spatially depen-
dent alterations in APP-KO Ca2+ amplitude as a consequence of either increased
response of rod and puncta mitochondria or decreased network Ca2+ signal. These
findings further confirm that mitochondrial morphology closely relates to appropriate
Ca2+ signalling in which APP plays a crucial role.
Together with slower kinetics of mitochondrial Ca2+ signals, these findings in pri-
mary astrocyte cultures partially resemble the decreased astrocytic Ca2+ transient
kinetics observed in microdomains in the cortical slice.
3.2.4 Mitochondrial proteins
Mitochondrial proteins in primary astrocyte culture
Mitochondrial fragmentation and altered stimulated Ca2+ response in primary astro-
cyte culture of APP-KO animals were observed prompting the question which mito-
chondrial mechanism is affected in the absence of APP. Hence, mitochondrial proteins
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associated with mitochondrial features related to energy production, Ca2+ uptake and
fission/fusion were analysed from primary astrocyte culture lysates by western blot.
The levels of the electron transport chain component cytochrome C were increased
in APP-KO astroyctes. Elevated levels and release of cytochrome C are a sign of
apoptosis [214]. However, one of the mitophagic markers TOM20 [266], which also
serves as an mitochondrial housekeeping protein, is not reduced in the tissue culture
lysates. Thus, mitochondria in APP-KO astrocytes are not reduced. The elevated
cytochrome C levels probably come along with the mitochondrial dysfunction but
without mitochondrial loss. Whether cytochrome C is actually released by mitochon-
dria and apoptosis is initiated in APP-KO astrocytes would have to be examined in a
prospective study.
The uptake of Ca2+ from the cytosol is performed by the mitochondrial Ca2+
uniporter (MCU) [267]. As stimulated mitochondrial Ca2+ responses were altered in
APP-KO astrocytes, the levels of MCU were examined in astrocyte lysates. No signifi-
cant alteration was observed. As the stimulated response amplitudes in mitochondrial
Ca2+ signalling differed within areas of one cell (edge/network ratio) and did not re-
veal any signficant change when the entire mitochondrial Ca2+ signal was taken into
account, a whole cell western blot approach might not be sensitive enough to detect
potential local differences in protein concentrations. For instance, it could be possible
that fragmented mitochondria differ in protein composition and therefore function in
comparison to mitochondria of the network type.
The ratio of phosphorylated DRP1 (pDRP1) and DRP1 is a common mechanism
to evaluate fission events in mitochondria [268],[269]. Mitochondrial fusion and fission
events are getting imbalanced in the incidence of injury or pro-inflammatory stimuli
in acute slices. Thereby, an increased mitochondrial fission and increase in the acti-
vated (phosphorylated) form of Drp1 were detected [257]. APP-KO astrocytes did not
exhibit any change in the pDRP1/DRP1 ratio indicating no involvement of DRP1 in
the observed mitochondrial fragmentation in APP-KO astrocytes. However, altered
DRP1 levels have been reported in the context of AD [270],[271],[114] and APP [109].
DRP1 has been shown to be reduced when AICD is overexpressed in SH-SY5Y cells
[265]. The protein Mitofusin-2 was also decreased in this study. The decrease in these
proteins was associated with decreased levels of mitochondrial housekeeping proteins
TOM20 and TIM23 suggesting reduced protein levels as a consequence of mitochondria
loss.
Mitofusin 1 and mitofusin 2 are implicated in mitochondrial fission and fusion
and also alocated to ER via MAM [272]. It has been shown that decreased levels
of Mitofusin-2 promote ER-mitochondria contact sites followed by increased Ca2+
transfer from ER to mitochondria and decreases intra- and extracellular levels of
Aβ [273]. APP and BACE1 expression were not altered as a consequence to knock-
down of mitofusin-2. However, γ-seceretase complex function was impaired suggesting
ER-mitochondria contacts as regulatory unit for APP processing and Aβ generation.
Maybe within this interplay, the presence of APP might be important for mitofusin
levels. Hence, it would be of interest to check the levels of mitofusin-1 and -2 in
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APP-KO astrocytes.
Generally, further investigations of mitochondrial function such as mitochondrial
membrane potential [110], ATP production, cytochrome C release, measurements of
mitochondrial membrane potential and of other electron transport chain proteins (e.g.
OXPHOS) will shed light on the mechanisms in which APP plays a crucial role.
Notably, cultured astrocytes are uncoupled from the complex cellular interaction
within the brain. Hence, examination of astrocytes interacting with neurons and
other cell types in the intact brain would be of great value for unravelling the role of
astrocytes and their proteins.
Isolation and protein investigation of astrocytes derived from the adult
mouse brain
Primary astrocyte cultures mature by time and get purified by passaging from culture
dish to culture dish. Findings from cell cultures cannot be related to the whole brain
condition, as important signalling among different cell types is missing. Therefore,
astrocytes were isolated from the adult brain in order to assess the changes in protein
concentration due to the lack of APP. The elaborate protocol succeeded and the as-
trocytes isolated from the adult brain were maintained in a culture dish or lysed for
western blot analysis. However, it is a work-intensive procedure that requires a lot of
biological material resulting in very small yield.
Although the yield of this approach is quite small, the value is of great importance,
as it allows selective analysis of astrocytes matured in the brain. Hence, experiments
should be adjusted to the little amount of astrocytes in culture and small protein con-
centration in the lysate. A western blot machine for small protein concentrations and
little volume (e.g. proteinsimple Wes) would be an option. Additionally, the protein
content of astrocytes isolated from the adult brain could be analysed with proteomic
analysis such as mass spectometry which does not require large amounts of protein and
potentially reveals additional proteins that are related to APP. Mitochondria of adult
astrocytes could also be further isolated and functionally or molecularly analysed.
Furthermore, astrocytes isolated from the adult brain could be plated on coated glass
coverslips and employed for mitochondrial morphology investigations testing compa-
rability to primary astrocyte culture. Moreover, this experiment would be closer to in
vivo or slice conditions, as the astrocytes matured in an intact tissue environment.
Surprisingly, a study has shown that APP is predominantly expressed by pyrami-
dal neurons but not in GFAP-positive astroglial cells in the adult mouse hippocampus
[274]. In the aforementioned study, the presence of APP was investigated by im-
munofluescence and in situ hybridisation. Here, expression of APP in hippocampal
astrocytes was confirmed by western blot analysis of astrocytes derived from the adult
hippocampus. Additionally, as dendritic spine alterations could be observed after
GFAP promoter dependent cAPPKO in the hippocampus, the presence of APP in
GFAP-positive astrocytes can be assumed.
Isolation of astrocytes from the adult brain is a reliable but work-intensive tool for
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culturing adult astrocytes that matured in the brain and for protein analysis. But, the
method requires large amounts of biological tissue in relation to very small yield. A
further step in selective isolation of biological material from the intact brain could be
the isolation of astrocytic mitochondria from the adult APP-KO brain. Subsequently,
proteomic and EM analysis could provide information about the function of APP
in mitochondria in vivo. These investigations could more closely link the observed
mircodomain size and Ca2+ transients to a mitochondrial phenotype.
3.2.5 Conclusion II
This study describes a plasticity deficit in APP-KO animals within the cortex and
hippocampus that is associated with malfunction of astrocytes as part of the tripar-
tite synapse. The task of astrocytes within this interplay are among others release of
D-serine for potentiation of the NMDAR at the postsynapse in order to strengthen the
signal. Moreover, astrocytes are highly involved in clearance and release of glutamate.
Both D-serine and glutamate have been shown to be regulated by elevations in intra-
cellular Ca2+ within astrocytic microdomains. Even further, it has been shown that
neuronal activity and glutamate localisation and level are associated with the localisa-
tion and mobility of mitochondria in astrocytic protrusions [254]. APP-KO astrocytes
might be in an inflammatory state [89] that involves mitochondrial fragmentation in
astrocytes [257] and consequently directly affects gliotransmission involving D-serine
release [96] and glutamate uptake [254]. Thereby, neurons display altered functional
and structural plasticity which differs among cortex and hippocampus. The differences
in neuronal plasticity across brain regions might derive from involvement of astrocytes
of different populations across brain regions.
Within the APP-KO astrocyte perisynaptic Ca2+ transient changes might be
linked to the disturbed mitochondria integrity manifested by mitochondrial fragmen-
tation and disturbed Ca2+ signalling. Physiological levels of APP are important for
mitochondrial morphology [115] and localisation [69], high abundance of APP cleavage
products such as C99 are associated with mitochondria-ER contact sites [106], Aβ is
localised in mitochondria [70] and can inhibit mitofusin levels [275], and full-length
APP can localise in TOM40 interfering with protein import into mitochondria [107].
Hence, APP and its cleavage products can interfere at several action sites in mito-
chondria e.g. fission and fusion proteins, ER-mitochondria proximity, protein import
into mitochondria that influence Ca2+ homeostasis (Figure 3.1). It remains elusive
to which extend physiological levels of APP and its cleavage products contribute to
appropriate mitochondrial function.
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Figure 3.1. Potential interaction sites of APP with the ER and mitochondria that affect
Ca2+ homeostasis. APP and its cleavage products have been shown to effect ER and mitochon-
dria function which are potential explanations why Ca2+ homeostasis is altered and mitochondria
are fragmented in APP-KO astrocytes. Thereby, potential sites of actions are the ER-mitochondria
contact sites involving mitofusin. Close proximity of ER and mitochondria is important for ap-
propriate Ca2+ signalling. Secondly, levels of mitochondrial fission and fusion proteins DRP1 and
mitofusin were shown to be affected by the lack of APP and have been shown to be aberrant in
AD. Furthermore, full-length APP can control import of mitochondrial proteins through the TOM
complex which might also affect the protein composition within the mitochondria. Aβ can localise
in the mitochondrial lumen where it can cause mitochondrial dysfunction.
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3.3 Relevance of APP studies for understand-
ing AD
The physiological role of APP for neuronal plasticity and associated astrocytic function
is further investigated in the present thesis. As it has been shown that protease
BACE is elevated in AD patients and full-length APP and neurotrophic APPsα are
reduced in brains of AD patients [276], it is reasonable to assume that reduction of
full-length APP and the imbalance of its cleavage products might be an additional
causative factor for the disease besides the accumulation of Aβ. The memory deficits
in AD patients correlate best with synapse loss and not with Aβ plaque burden or
neurofibrillary tangles [23]. Hence, it is crucial to understand the physiological role of
APP on synapses including astrocytic contribution for the development of therapeutic
strategies. For instance, BACE1 inhibitors reduce the level of Aβ but also implicate
a change in increased levels of full-length APP and other APP cleavage products.
Astrocytes should also be clearly considered in therapeutic approaches for the
treatment of AD, as APP plays a crucial role in astrocytic Ca2+ signalling which is
essential for associated neuronal function.
Regarding the features and physiological consequences of astrocyte-neuron sig-
nalling, important questions remain, as molecular and cellular events and consequences
on whole brain function and further on animal behaviour are not fully understood.
Moreover, the implication of astrocyte-neuron signalling integrity in any brain pathol-
ogy requires further research [144]. This study provides further steps on the way to
comprehend the physiological role of APP at the tripartite synapse which is crucial
for brain network function. In addition to that, the findings highlight critical aspects
of APP function which need to be considered for AD therapy.
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4. Materials and Methods
4.1 Genetically modified mouselines, genotyp-
ing and husbandry
4.1.1 Mouse lines
The following genetically modified mouse lines were used:
APP-KO
Constitutive KO if the amyloid precursor protein: APP-KO [198],[101], [277].
Apptm2Cwe; MGI:2154535
APP flox
Conditional null allele for APP: APP fl [207]
Apptm3.1Umu; MGI:4822174
GFP-M
Labelled subset of principal neurons in hippocampus and cortex: GFP-M [208]
Tg(Thy1-EGFP)# Jrs; MGI:4941461
Wild type
Control animals were either WT littermates or C57BL/6J from Jackson Laboratory.
4.1.2 Genotyping
The genomic DNA of the mice was isolated from ear or tail biopsies by the pegGold
Tissue DNA Mini Kit (Peglab) in 96-well plates. The tissue was incubated in 400
μl lysis buffer containing proteinase K and RNase at 50◦C over night. Subsequently,
a subernatant was generated by centrifugation (1 min, 10000 rpm, Eppendorf Cen-
trifuge 5804) which was mixed with 400 μl DNA binding buffer. Next, the solution
was loaded onto DNA binding columns (PerfectBind) and centrifuged (1 min, 10000
rpm). The DNA bound to the columns was washed twice (washing buffer followed by
1 min centrifugation 10000 rpm) and eluted (200 μl elution buffer, 3 min incubation,
and 1 min centrifugation 6000 rpm). Subsequently, the isolated DNA was amplified by
polymerase chain reaction (PCR, Thermocycler Eppendorf) by using specific primer
and PCR protocols for mouse line genotyping (see below). Following, the genotype of
the mice was defined by the electrophoresis of the DNA bands on an agarose gel which
depends on the size of the amplified DNA fragment.
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APP-KO
Fragments: ca. 650-700bp (WT) und ca. 430 (KO)
Primer:
Name Sequence 5’ → 3’ Tm (◦C)
1 CGA GAT CAG CAG CCT CTG TTC CAC A 57,4
2 ATC ACC TGG TTC TAA TCA GAG GCC C 59,2
3 GAG ACG AGG ACG CTC AGT CCT AGG G 56
PCR sample:
Volume (μl) Product Concentration
12.5 OneTaq HotStart QuickLoad, NEB (x2 MM)
0.5 Primer 1 10 μM
0.5 Primer 2 10 μM
0.5 Primer 3 10 μM
1 Template DNA
10 H2O
PCR programme:
Step Temperature (◦C) Time (s) Repeats
Denaturation 94 180 1 ×
Denaturation 94 30
Hybridisation 60 60 27 ×
Elongation 68 50
Elongation 68 300 1 ×
10 unlimited
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APP flox
Fragments: 342bp (WT) und 388bp (APPflox)
Primer:
Name Sequence 5’ → 3’ Tm (◦C)
1 TGC ATG TCA GTC TAA TGG AGG C 58
2 ATC TGC CCT TAT CCA GTG AAA TGA ACC C 60
PCR sample:
Volume (μl) Product Concentration
12.5 OneTaq HotStart QuickLoad, NEB (x2 MM)
0.5 Primer 1 10 μM
0.5 Primer 2 10 μM
0.5 Template DNA
11 H2O
PCR programme:
Step Temperature (◦C) Time (s) Repeats
Denaturation 94 180 1 ×
Denaturation 94 30
Hybridisation 59 60 27 ×
Elongation 68 30
Elongation 68 120 1 ×
10 unlimited
74
4.1 Genetically modified mouselines, genotyping and husbandry
eGFP-M
Fragments: Transgene 173 bp
Primer:
Name Sequence 5’ → 3’ Tm (◦C)
1 AAG TTC ATC TGC ACC ACC G 56,7
2 TCC TTG AAG AAG ATG GTG CG 57,3
PCR sample:
Volume (μl) Product Concentration
12.5 OneTaq HotStart QuickLoad, NEB (x2 MM)
0.5 Primer 1 10 μM
0.5 Primer 2 10 μM
1 Template DNA
10.5 H2O
PCR programme:
Step Temperature (◦C) Time (s) Repeats
Denaturation 94 180 1 ×
Denaturation 94 30
Hybridisation 60 60 27 ×
Elongation 68 20
Elongation 68 120 1 ×
10 unlimited
75
4. Materials and Methods
4.1.3 Husbandry
All animals were bred in the animal housing facility of the Center for Neuropathology
and Prion Research and the Center for Stroke and Dementia of the Ludwig Maximilian
University Munich. Mice were group-housed with up to six individuals in standard
cages (30 × 15 × 20 cm), with standard bedding and additional nesting material
under pathogen-free conditions, with food and water provided ad libitum. Mice were
kept under a 12/12-hr light/dark cycle. At the age of 2 months, virus injections were
performed.
4.2 Genetic modifications via viruses and plas-
mids
4.2.1 Viruses
Conditionally inducible Cre recombinase expressed under the GFAP
promoter
AAV GFAPCreERT2 Penn Vector, Philadelphia, PA, USA.
GFAPCreERT2 virus (AAV5Penn Vector)
Conditional reporter fluorophore
AAV Brainbow Penn Vector, Philadelphia, PA, USA.
AAV9.hEF1a.lox.mCherry.lox.mTFP1.lox.WPRE.hGH-InvCheTF (Harvard)
4.2.2 Plasmids
Primary astrocytic cultures were transfected with plasmids for reintroduction of APP
and for astrocytic specific expression of a Ca2+ indicator in mitochondria.
APP-GFP plasmid
The plasmid was kindly provided by Prof. Dr. Stefan Lichtenthaler.
Full name of the plasmid: p12/HA-APP-GFP.
APP CT is fused to GFP and NT fused to HA tag enabling CT (GFP) and NT (HA)
detection of the protein. The expression is controlled by the EF1α promoter. The
plasmid consits of 9871 bp.
Astrocytic-specific expression of mitochondrial-targeted GCaMP6
The astrocytic mitochondrial Ca2+ indicator GCaMP6 (mitoGCaMP6) was kindly
provided by Prof. Shinghua Ding, PhD [278].
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Full Name of the plasmid: pZac2.1-ABC1D-mito-GCaMP6s.
The plasmid was amplified by bacterial inoculation followed by DNA extraction using a
Qiagen Midiprep kit. Plasmid information: Mitochondrial matrix (MM)-targeting se-
quence (mito-) ATGT CCGTCCTGAC GCCGCTGCTG CTGCGGGGCT TGACAGGCTC
GGCCCGGCGG CTCCCAGTGC CGCGCGCCAA GATCCATTCG TTG [279].
Sequencing Primer:
Seq-ABC1D F: TCTAGCCCACTCCTTCATAAAG;
Seq-ABC1D R: ATTTCACAAATAAAGCATTTTTT
The plasmid consist of 5630 bp.
4.3 Stereotactic virus injection
Surgery tools (Fine Science Tools, FST) were sterilised (Hot Bead Sterilizer, FST)
before start of the injection. Mice were anaesthetised before undergoing surgery by
intraperitoneal injection of ketamine/xylazine (120 and 10 µg/g body weight, respec-
tively; WDT/Bayer HealthCare). The depth of the anaesthesia was checked by pinch-
withdrawl reflex on the hind limb of the mouse. Additionally, the anti-inflammatory
drug Rimadyl (7.5 µg/g; Pfizer) and the antibiotic Baytril (7 µg/g body weight, Bayer
HealthCare) were subcutaneously administered. During the surgery the body temper-
ature of the mouse was kept at 37◦C, as the mouse was lying on a heating pad (FST).
The eyes of the mouse were prevented from drying by application of Bepanthen eye
ointment (Bayer). The head of the mouse was fixed between two ear bars of a stereo-
tactic injection setup. The head of the mouse was orientated planar for stereotactic
injection and cleaned with 70 % ethanol. The surgery was conducted through binoc-
ulars with a cold light source. The skin over the skull was longitudinally cut with
a scalpel in order to expose the skull over the cortex. The skull and edges of the
skin were cleaned with a scalpel, forceps and cotton sticks by removing loose hair,
blood and connecting tissue. A hole was drilled in the skull on top of the right so-
matosensory cortex, 2 mm posterior and 2 mm lateral of bregma. The injection glass
capillary (pulled with vertical puller, Narishige) mounted on the stereotactic device
was loaded with the virus, respectively. The capillary was inserted into the brain for
virus injections at three different injection depths from the brain surface: 1) 2 mm
hippocampus dentate gyrus, 2) 1.4 mm hippocampus CA1 and 3) 0.3 mm cortex. In
each injection site 300 nl virus was released with a speed of 30 nl/min. After each
injection, the capillary was kept for 1 min at the injection site before moving to the
next one. After virus application, the hole in the skull was closed with bone wax and
the skin sewed with sutures. The animals were transferred into a 37◦C incubator or
onto a heating pad to allow waking up under warm conditions. The recovery of the
animal was checked daily and the brain was harvested after several months depending
on the experiment.
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4.3.1 Investigation of the role of APP in astrocytic Ca2+
transients
For perisynaptic astrocytic Ca2+ imaging the AAV2/5 GfaABC1D Lck-GCaMP6f
virus (# 52924, Penn Vector, Philadelphia, PA, USA) with a strong membrane tar-
geting dual acylation motif from Lck protein tyrosine kinase, in a of 10% virus (titer
1012 vg/ml, 45% PBS (1x) and 11.25 % mannitol solution, for a final volume of 300
nl/injection site was injected into the hippocampus and cortex of APP-KO and WT
animals. Due to the low expression of the virus, the expression duration was defined
to 4-5 months before astrocytic Ca2+ imaging of acute brain slices was commenced
with a two-photon microscope.
4.3.2 Investigation of the role of APP in dendritic spine
density and morphology
For conditional KO of APP in a subset of astrocytes and simultaneous labelling of
those, Cre recombinase and a conditional reporter fluorophore were introduced in a
subset of astrocytes: GFAPCreERT2 AAV & Brainbow AAV (2 × 10% virus (titer
1012 vg/ml, 45% PBS (1 ×) and 35% of 8.75% mannitol solution were injected in the
hippocampus and cortex of APPfl/fl x GFP-M and APP+/+ x GFP-M mice. The
virus was expressed for 10 weeks followed by one week of tamoxifen application (in-
traperitoneal injection of tamoxifen (Sigma) in miglyol (Caesar & Lorentz) 20 mg/ml;
40 mg/kg bodyweight) and another 10 weeks of the Cre recombinase (CreERT2, ta-
moxifen inducible) activity and fluorophore expression. Finally, the animals were per-
fused and the brain harvested for immunohistochemical investigations and confocal
microscopy.
4.4 Electrophysiology in acute brain slices
4.4.1 Patch clamp recordings
Acute brain slice preparation for patch clamp recordings
Animals were deeply anaesthetised by 5% isoflurane inhalation. The depth of the
anaesthesia was checked by the pinch-withdrawl reflex of the hind limb. The animals
were quickly decapitated and the head was immediately placed into ice-cold cutting
solution (in mM: 75 sucrose, 85 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 D-
glucose, 4 MgCl2, 0.5 CaCl2; pH = 7.4) which contained ice crystals and was bubbled
with carbogen (95% O2, 5% CO2) for >20 min. The brain was quickly and carefully
dissected and placed in fresh cutting solution. Subsequently, the brain was trimmed
by disconnecting the cerebellum and forebrain. In order to obtain coronal sections,
the brain was glued on the cutting surface of the cerebellum. 300 µm thick slices were
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prepared with the Leica VT1200S with integrated cooling chamber filled with ice cold
cutting solution. The slices were taken with the numb end of a Pasteur pipette and
transferred in a submerged holding chamber containing aCSF (in mM: 125 NaCl, 2.5
KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 D-glucose, 2 MgCl2, 2 CaCl2) that was warmed
in a water bath at 34◦C. Slices were kept at 34◦C for 30 min followed by transfer of
the holding chamber to RT were the temperature was slowly decreasing. After 1 h at
RT the slices were employed for patch clamp recordings in aCSF.
Cortical NMDA/AMPA patch clamp recordings
Stimulated NMDA/AMPA recordings were performed in layer V cortical pyramidal
cells of 3-months old mice of both sexes. For recordings, a glass microelectrode (3-5
MΩ, produced by P-97 Puller, Sutter Instruments) was filled 1/3 with intracellular
solution (in mM: 140 CsCl, 5 Lidocaine N-ethyl bromide (QX-314, Sigma), 10 KCl, 5
NaCl, 0.01 EGTA, 10 HEPES, 2 MgATP; pH=7.4; Osmol/kg=300) and aCSF (in mM:
125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 glucose, 2 MgCl2, 2 CaCl2). Low
MgCl2 conditions (0.5 mM) were obtained to facilitate the release of the Mg
2+ block
in the NMDAR. Stimulation (bipolar electrode) steps at different holding potentials
in mV: -90. -80, -70, -60, -50, -40, -30, -20, -10, 0, 10, 20 ,30, 40, 50, 60, 70 served
for the optimisation of the NMDAR response recording conditions. In the presence of
Picrotoxin (Sigma, GABAA receptor antagonist) 50 µM and low Mg2+ (0.5 mM) aCSF
the AMPAR response was recorded at -90 mV holding potential. Subsequently, the
cell was clamped at +40 mV for the additional NMDAR current present through the
depolarisation of the membrane. The ratio of NMDA/AMPA current was calculated
from the response at +40 mV. Thereby, the AMPAR response was considered at the
timepoint of the peak at -90 mV and the NMDAR component 40 ms after the stimulus
artifact. The resistance was checked before the measurements at -90 mV and after at
+40 mV with a 10 mV test pulse, respectively.
4.4.2 LTP recordings
Acute brain slice preparation for local field potential recordings
Animals were deeply anaesthetised by 5% isoflurane inhalation. The depth of the
anaesthesia was checked by pinching the mouse between the toes of the hind limb.
The animals were quickly decapitated and the head was immediately placed into ice-
cold cutting solution (in mM: 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25
D-glucose, 6 MgCl2, 0.5 CaCl2; pH = 7.4) was contained ice crystals and were bubbled
with carbogen (95% O2, 5% CO2) for >20 min. The brain was quickly and carefully
dissected and placed in fresh and bubbled cutting solution. Subsequently, the brain
was trimmed by disconnecting the cerebellum and forebrain. In order to obtain coronal
sections, the brain was glued on the cutting surface of the cerebellum. 350 μm thick
slices were performed with the Leica VT1200S with integrated cooling chamber filled
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with ice cold cutting solution. The slices were taken with the numb end of a Pasteur
pipette and transferred in a submerged holding chamber containing aCSF (in mM: 125
NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25 glucose, 2 MgCl2, 2 CaCl2) that was
warmed in a water bath at 34◦C. Slices were kept in at 34◦C for 30 min followed by
transfer of the holding chamber to RT where the temperature was slowly decreasing.
After 1 h at RT the slices were employed for LTP recordings.
Hippocampal LTP recordings
Animals of 3-4 months of age of both sexes were used for acute slice preparation
followed by LTP recordings. Experimental groups: WT and APP-KO, both either
non-treated or treated with D-serine supplemented to the drinking water (0.55 mg/ml
D-serine (Sigma) dissolved in drinking water for 4 weeks starting when animals were 3
months of age, preparing a fresh bottle every second day). In another experiment, 10
μM D-serine was washed into the recording chamber containing the acute brain slice.
Prepared brain slices were transferred into a submerged recording chamber for
recordings of field excitatory postsynaptic potentials (fEPSPs). Therefore, two plat-
inum/iridium concentric electrodes (PI2CEA3, Life Science) were placed on the surface
of the slice on the Schaffer-collaterals in the stratum radiatum of the CA1. For record-
ing a glass microelectrode (1-3 MΩ, produced by P-97 Puller, Sutter Instruments) was
filled 1/3 with aCSF and placed in the CA1 stratum radiatum between the two stim-
ulation electrodes. The stimulation electrodes sent a single pulse in an alternating
manner with 15 s inter-stimulation interval and 30 s from one side. This interval is
necessary for preventing paired facilitation responses. After positioning the electrodes,
the initial stimulation was mild and just enough to elicit a fEPSP of <0.5 mV for ∼10
min. Following, the setting was used for input/output (I/O) curve generation. There-
fore, the stimulator was set to a value that no fEPSP was detectable. This value
differed among slices and electrode position (1.5 -3.5 mV). Then, the stimulation was
raised in 0.5 mV steps until a fiber volley appeared. Afterwards, it was raised one more
time for 0.5 mV. The fEPSPs of a range of 4.5 mV were employed for generating an
I/O curve. Next, the stimulus was set to a value that generates half of the maximum
response for paired pulse facilitation (PPF) experiments. The intervals between the
two stimuli were 20, 30, 50, 75, 100 ms.
Subsequently, the LTP recordings were performed. Therefore, the stimulus in-
tensity was individually adjusted for each experiment to produce fEPSPs, which are
30-40% of the maximal responses. Every 30 s a stimulus from each site was elicited
alternating with each other, resulting in fEPSP every 15 sec. Once the response was
stable and no longer raising, the baseline was recorded for 20 min. In order to induce
LTP, 100 stimuli of high frequency stimulation (HFS) of 100 Hz was applied. Stimu-
lated fEPSP recordings (with stimulation intervals as during baseline recordings) were
continued for 60 min after HFS.
The field potentials were amplified 100 × using an EXT-10C amplifier (National
Instruments) and digitised with BNC-2090A (National Instruments). 1-4 LTP record-
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ings were performed per animal from two setups. Data were analysed with WinLTP
2.10 programme. For the analysis of the LTP, fEPSP from one site were averaged over
one minute, to obtain one data point per minute (2 stimuli per minute from one site).
This enabled two independent LTP recordings from one slice.
4.5 Astrocytic Ca2+ imaging in acute brain slices
4.5.1 Two-photon Ca2+ imaging in astrocytic protrusions
The acute brain slices were prepared as for LTP recordings. For astrocytic Ca2+
imaging, the Ca2+ content of the aCSF in the imaging chamber was slightly increased
(2.5 mM) in order to favour Ca2+ activity in the slice. For two-photon imaging of
acute slices the incubated brain slices were transferred in a submerged chamber under
a two-photon microscope (LaVision). Constant perfusion of aCSF saturated with
carbogen ensured survival of the slice. The bath temperature was set to 32◦C and
the perfusion rate was 4 ml/min. Before image acquisition, the orientation in the
slice and expression of the Ca2+ indicator was checked bright field microscopy. When
an imaging region was chosen time-lapse image series of GCaMP6f fluorescence were
acquired in the hippocampus or cortex. The fluorescence image series were obtained
by LaVision Trim Scope with a Spectra-Physics femtosecond pulsed Ti:Sa laser (Mai
Tai, DeepSee) tuned to 920 nm and W Plan-Apochromat 20×/1.0 DIC objective
water immersion (Zeiss). The microscope was controlled by using LaVision Imspector
software (LaVision BioTec GmbH, Bielefeld, DE) while the laser was regulated by the
Mai Tai software. The image series were acquired at a rate of 2 Hz in a frame of 69 ×
69 μm with a resolution of 1024 × 1024 pixel. Every image series lasted for 300 sec.
The laser power was kept below 20 mW.
4.5.2 Analysis of astrocytic Ca2+ transients
After image acquisition, the image series were further processed for analysis of the
Ca2+ transients. The protocol used for astrocytic Ca2+ activity investigations was
adapted from the protocol CaSCaDe (Ca2+ Signal Classification and Decoding) [195].
Thereby, the detection of microdomains and extraction of Ca2+ traces was performed
with Fiji, while the trace analysis was semi-automatically done with MiniAnalysis
Software (Synaptosoft Inc., Decatur, GA, USA). Firstly, x-y drift of the image series
was corrected by using Igor 7 Pro software (WaveMetrics Inc., Lake Oswego, OR,
USA), followed by cropping to 60 × 60 μm. The aligned and cropped image series
was further processed with Fiji: The background noise was subtracted by performing
3D convolutions (average and Gaussian filters of size 25 × 25 × 25 pixels (x,y,t))
on the image series. Subsequently, Gaussian filtering product was substracted from
the average image stacks resulting in a noise-filtered image stack (I(x,y,t)). In order
to identify regions that exhibit frequent dynamic changes in fluorescence, the mean
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intensity (AVG) and standard deviation (STD) of noise-filtered image series were per-
formed resulting in a 2D (x-y) projection. From the sum intensity of AVG + 3 × STD
a threshold value was generated that was used for binarising sum and STD projections
(2D) of the image series. The sum of the two binarised (sum and STD) pictures was
the mask for detected microdomains/ROIs, again Gaussian filtered (25) for core de-
tection. Number and size of active microdomains was taken into account for analysis.
The ROIs were finally applied on the raw image series for extraction of Ca2+ traces.
Only active microdomains were taken into account. Spontaneous Ca2+ events were
analysed and characterised with the MiniAnalysis 6.0.07 software (Synaptosoft, Inc.,
Decatur, GA, USA): Spontaneous events were manually marked, event amplitudes,
area under the curve, rise and decay time and event frequency per ROI/min were
determined.
4.6 Ex vivo analysis of dendritic spines
4.6.1 Perfusion
Mice were anaesthetised by intraperitoneal injection of ketamine/xylazine (120 and
10 µg/g body weight, respectively; WDT/Bayer HealthCare) before undergoing per-
fusion. They were transcardially perfused with phosphate buffered saline (1 × PBS)
until blood was washed out (5 min) followed by 4% paraformaldehyde in 0.12 M PBS
(15 min), pH: 7.4. The brain was dissected and post-fixed for 24 h at 4◦C in the same
fixative. The next day, the brain was placed in 1 × PBS + 0.05% sodium azide until
slicing and immunohistochemistry.
4.6.2 Brain slicing
For staining with antibodies, the brain was coronally cut with a vibratome Leica VT
1000S (Leica Mikrosysteme Vertrieb GmbH, Wetzlar, Germany) from Bregma 1.4 -
2.2 with a thickness of 50 µm and transferred into 24-well plates containing 1 × PBS
+ 0.05% sodium azide. The immunohistochemical stainings were performed on free-
floating sections in 24-well plates.
4.6.3 Immunohistochemical staining
Slices were permeabilised (2% Triton X-100 in 1 × PBS, Life Science, Darmstadt, DE)
on the horizontal shaker overnight at 4◦C. In order to prevent unspecific binding of the
antibodies, the slices were blocked in blocking solution (10% normal goat serum in 1 ×
PBS, Thermo Fisher Scientific Messtechnik GmbH, Munich, DE) for 2 h at RT. Slices
were incubated with primary antibodies (see list) in blocking solution (10% normal
goat serum, 0,03% Triton-X, 0,05% sodium azide in 1 × PBS) overnight at 4◦C. The
next day, slices were washed 3 × with 1 × PBS for 10 min at RT and the secondary
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antibody was applied for 2h at RT. After 3 × washing with 1 × PBS brain slices were
mounted on polysine slides and embeded in Dako Fluorecent Mounting Medium (#
S3023, Thermo Fisher Scientific Messtechnik GmbH, Munich, DE).
4.6.4 Confocal microscopy
Images of the dendrites and astrocytes were obtained in the cortex and hippocampus
with the confocal microscope Zeiss LSM 780 with a Plan Apochromat 40×/ NA 1.4 Oil
DIC objective with the pinhole set to 1 airy unit for high resolution image acquisition.
First a region where an astrocyte expresses mCherry and thus lacks APP was chosen
and imaged as a small overview (pixel: 512 x 512; zoom around 2.5 depending on
astrocyte size; pixel dwell: 1.58 µs; 1 µm z-resolution; example size of an overview
picture: x: 84.85 µm, y: 84.85µm, z: 31.00 µm) for orientation of the dendrites. This
picture served for choosing the dendrites for detailed acquisition: the zoom function
was used for a more detailed image of the dendrite (pixel: x: 1024, y: 256; z=
depending on dendrite orientation. 0.5 µm z-scaling; picture size: x: 59.93 µm, y:
14.94 µm; zoom: 3.5; pixel dwell: 1.58µ s, 2x avg.; 8-bit; Channel 1: 488 nm, 1.5%;
Channel 2: 561 nm, 2.0%). Overview tile scans for illustration on the expression
pattern were obtained with a 20×/NA 0.8Plan Apochromat Air objective and in the
tile scan mode.
4.6.5 Dendritic spine counting and morphological inves-
tigation
Images were analysed with ZEN software as 3 dimensional image stacks and a built-in
overlay (.ovl) mask in combination with the SpineMiner programme by Simon Ochs.
All data was blindly and manually analysed. Firstly, the length of the dendrite sur-
rounded by the mCherry expressing astrocyte was determined by drawing an Open
Bezier along the part of the dendrite that was surrounded by red fluorescent signal.
Next, the spines along the measured dendrite segment were counted and classified
in the morphological spine classes stubby, thin and mushroom spine in z-stacks by
manually scrolling through the images. In the somatosensory cortex basal dendrites
were taken into account, as it was impossible to find enough dendrites passing through
mCherry-positive astrocytes in layer I of the cortex. In the hippocampus basal and
apical dendrites of the CA1 region were analysed.
4.7 Primary astrocyte culture
4.7.1 Preparation
Primary cortical astrocyte cultures were prepared on postnatal day 3 (P3) from APP-
KO and WT animals. The brain was isolated and placed in HBSS (Gibco, cat.
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24020091, Thermo Fisher Scientific) + HEPES (3.5 ml 1M in 500 ml HBSS) at RT.
Meninges were removed and the cortex was dissected. Cortices from 3 animals were
pooled, cut into pieces, washed with HBSS, and digested in 5 ml Trypsin containing
0.05% EDTA (Gibco; cat. 25300062, Thermo Fisher Scientific) at 37◦C for 15 min.
The reaction was stopped by adding 5 ml of medium (MEM (Gibco cat. 31095029,
Thermo Fisher Scientific), 0.6% Glucose (Merck # 1083371000, CAS 50-99-7), 5%
heat-inactivated FBS (PAN Biotech P40-37500)). After washing with HBSS, cells
were mechanically dissociated by pipetting in culture medium to obtain a single-cell
suspension and plated on a T-75 flask (Nunc EasY Flask cat. 156499, Thermo Fisher
Scientific). The medium was changed the next day in order to remove unattached
cells. Cultures were grown in an incubator with humid environment at 37◦C and 5%
CO2 (Hereaus, HERAcell 150i). Astrocytic cultures were split at 90% confluency by
transferring the cells equally in T-175 flasks (Nunc EasY Flask cat.159910, Thermo
Fisher Scientific).
For transfection and immunofluorescence experiments astrocytes were plated on cov-
erslips: During the second passaging procedure cells were plated on 15 mm glass
coverslips (Marienfeld) in a 12-well plate (Nunc cat. 150628, Thermo Fisher Scien-
tific) at a density of 70 000 cells per well. Before plating the cells, the coverslips were
pretreated overnight (o/n) in nitric acid (Merck), washed 3 × with H2O, and sterilised
in an oven (Memmert UF30) for 8 h.
For cell lysis followed by protein investigation via western blot, astrocytes were kept
in flasks.
4.7.2 Plamid transfection
Astrocytes grown on coverslips for 72 h were washed once with 1 × PBS. Cells were
transfected by incubating 1 μg plasmid encofing a mitochondria-targeted Ca2+ indica-
tor GCaMP6 (mitoGCaMP6) or APP-GFP plasmid with 1.5 µl lipofectamine (lipofec-
tamine 2000 reagent, Invitrogen) in OptiMEM (Gibco, cat. 51985026, Thermo Fisher
Scientific) + 2.5% FBS over night in the incubator at 37◦C and 5% CO2. The medium
was changed the following day.
Day 5 after transfection with APP-GFP plasmid, the cells were washed with 1 × PBS
and fixed for 15 min with 4% PFA (Merck, 4% PFA (w/v) in 1 × PBS) at RT. After
washing with 1 × PBS, cells were used for immunofluorescence stainings.
Day 2 after transfection with mitoGCaMP6, the stimulated mitochondrial Ca2+ re-
sponse was investigated.
4.7.3 Investigation of mitochondrial morphology
Immunohistochemistry
Cover glasses were placed into a humid chamber, quenched for 10 min with 50 mM
ammonium chloride, and extracted with 0.1% Triton-X 1 × PBS (Live Sciences) for 3
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min at RT. In order to prevent unspecific binding, a 10% blocking solution (2% FCS,
2% BSA, 0.2% fish gelatin) diluted in 1 × PBS was applied on the coverslips for 1 h
at RT. The coverslips were incubated 1 hour at RT with the primary antibody diluted
in 10% blocking solution /1 × PBS (for a complete primary antibodies list see table).
After rinsing the coverslips 3 × with 1 × PBS we applied secondary antibodies diluted
in 10% blocking solution /1 × PBS. The secondary antibody applied, raised in goat
or donkey, were: Alexa 594, Alexa 488, and Alexa 647 diluted 1:500 in 10% blocking
solution /1 × PBS.
Confocal microscopy
Mitochondria of cultured astrocytes were stained against TOM20 (see table for pro-
tocol) and embedded with Dako Fluorescent Mounting Medium (S3023) on polysine
slides (Thermo Scientific, P4981). Confocal microscopy z-stack images were acquired
(x and y depending on size of mitochondria, z: between 3-6 µm, 0.5 µm interval;
Zeiss 40×/1.4, oil immersion) and 2D deconvolved (AutoQuantX3, Media Cybernet-
ics). Projection on the z-axis was performed to obtain a single in-focus field projection.
Mitochondria were selected by thresholding the pictures and classifying them using the
software Fiji. Classification of mitochondria morphology in network (from 8.9 µm2),
rods (rods area: 2.7 - 8.8 µm2) and puncta (0.1 2.7 µm2) was based on the pixel
coherence. A colour-coded image was generated to visualise mitochondrial morpholgy
distribution in red puncta, in green rods and in blue the network. The eGFP signal of
APP-GFP transfected cells was amplified by anti-GFP staining which allowed visual
identification of APP transfected astrocytes and investigation of their mitochondria.
For statistical analysis the morphological class is shown as fraction (%) of the total
mitochondria area (TOM20) of an astrocyte, n = 30 astrocytes.
4.8 Mitochondrial Ca2+ signals in cultured as-
trocytes
4.8.1 Two-photon imaging of mitochondrial Ca2+ signals
Primary astrocytes on cover slips were transferred to the imaging setup in a Petri
dish with 1xPBS. The coverslip was divided with a scalpel in three parts in order to
conduct more recordings from one coverslip and fit into the recording chamber. The
recording chamber was under constant perfusion of aCSF (in mM: 125 NaCl, 2.5 KCl,
1.25 NaH2PO4, 25 NaHCO3, 25 D-glucose, 2 MgCl2, 2 CaCl2) pH = 7.4, constantly
bubbled with carbogen (95% O2, 5% CO2) and the temperature was set to 32
◦C.
With transmission light the coverslip was screened for green fluorescently labelled
mitochondria. Subsequently, the fluorescence image series were obtained by LaVision
Trim Scope with a Spectra-Physics two-photon Ti:Sa laser (Mai Tai, DeepSee) tuned
to 920 nm and W Plan-Apochromat 20×/1.0 DIC water immersion objective (Zeiss).
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The microscope was controlled by using LaVision Imspector software (LaVision BioTec
GmbH, Bielefeld, DE) while the laser was regulated by the Mai Tai software. A
resonant scanner in unidirectional scanning mode was used. The laser was set to 1.5%
laser power and 77 gain for the PMT (photon multiplier tube). The image series were
acquired at a rate of 1 Hz in a frame of 69 × 69 µm with 1024 × 1024 pixel resolution
for 300 s. The settings were chosen in a way that fluorescent changes were detectable
with moderate bleaching rate. For stimulating a mitochondrial Ca2+ signal, either
10 µM ATP (adenosine 5’-triphosphate di(tris) salt hydrate, Sigma) were applied in
the perfusion system. When the substance reached the cells, they responded with
an increase of fluorescence signal in the mitochondria. This takes place due to Ca2+
release into the cytosol and subsequent influx of Ca2+ into the mitochondria via the
MCU (mitochondrial Ca2+ uniporter).
4.8.2 Data analysis of mitochondrial Ca2+ signals
The fluorescence signals were quantified by measuring the mean pixel intensities of
the regions of interest (ROI) around the entire mitochondrial signal. The first minute
before the rise of the fluorescent signal was employed as baseline. The drop of the curve
of the first minute was corrected on the entire image series to subtract the bleach rate.
Two exponential fits were applied on the decay of the signal. For fluorescence baseline
signal comparison, the fluorescence signal of the mitochondria was subtracted by the
baseline (two 55 pixel squared ROIs on the background). For analysis of the Ca2+
response of network and rod/puncta mitochondria, the amplitude (∆F/F) from a ROI
close to the nucleus and close to the cell edge were taken into account.
4.9 Protein extraction and immunoblotting
Western blot
Westernblot analysis was performed with 2x passaged astrocyte cultures. 5 cultures
prepared from 3 pups each were taken to obtain 5 biological replicates. After cells
reached 90% confluency they were detached by trypsinisation and lysed with STET
buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 2 mM EDTA, 1% Triton-X-100,) con-
taining 1:100 freshly added protease inhibitor (P8340, Sigma-Aldrich Chemie GmbH
Munich, De) and 1:100 phosphatase inhibitor (# 5870 Cell signaling) for 30 min on ice.
Protein concentration was determined with bicinchoninic acid (BCA) assay (Uptima
Interchim) and samples were mixed 1 in 4 with 4 × Laemmli buffer (8% SDS, 40%
Glycerol, 0.025% Bromophenol blue, 10% β-mercaptoethanol, 125 mM Tris, pH 6.8).
10-15 µg protein was loaded on a gradient gel (M42015, Genscript ExpressPlus PAGE
gel 4-20%) and SDS-PAGE was performed with Tris-MOPS-SDS Buffer (M00138, Gen-
Script,). Proteins were transferred onto a PVDF membrane (IPVH 00010, Merck) in
transfer buffer (25 mM Tris, 240 mM Glycin, 10% Methanol). The membrane was
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blocked with 5% skim milk (Sigma-Aldrich Chemie Gmbh Munich, De) in PBS-T (1x
Phosphate buffered saline + 0.05% Tween) for at least 30 min at RT with horizontal
rotation. After washing with PBS-T, the following antibodies were used for WB anal-
ysis: primary antibodies in PBS-T, 0.25% BSA and incubated o/n at 4◦C APPY188
1:1000, TOM20 1:1000 (see antibody list), 1h at RT β-actin 1:10000 (A5316, clone
AC-74, Sigma), 1 h at RT calnexin 1:10000 (ADI-SPA-860, Enzo); secondary anti-
bodies were diluted in 0.25% BSA in PBS-T and incubated for 1h at RT anti-mouse-
horseradish peroxidase (HRP) 1:10000 (Promega, Mannheim, De), anti-rabbit-HRP
1:10000 (Promega). Protein signals were developed with enhanced chemiluminescence
(ECL) (ECL-substrate, RPN3243, GE Healtcare) and visualised using ImageQuant
LAS4000 (GE Healthcare).
Membrane stripping
The membrane was placed in 1 M glycine in 1 × PBS and boiled 2 × for 10 min on
a heating plate. Following, it was cooled down at RT on the horizontal shaker and
washed 3 × for 15 min with PBS-T (0.1%) at RT.
4.10 Isolation of astrocytes from the adult mouse
brain
The isolation of astrocytes derived from the adult mouse brain was performed by
following the suggested protocol for the kit (Adult Brain Dissociation Kit and Anti-
ACSA-2 MicroBead Kit) of Miltenyi Biotec, Gladbach, Germany. Samples were kept
on ice or at 4◦C and fastly processed. The cortex and hippocampus were quickly
harvested and placed in a gentleMAC C tube, thereby, pooling two brains in one
tube containing enyzme mix 1 then enzyme mix 2 was added. The gentle incubation
and homogenisation was conducted by the gentleMACS Octo Dissociator with Heaters
with the programme 37C ABDK 01. After ∼30 min programme duration the sample
was collected at the bottom of the tube by centrifugation 300 rpm for 10 min at 4◦C.
The resuspended sample was run through a cell strainer (70 µm) in order to select
for single cells and small cell depris. The cells were centrifuged for 10 min at 4◦C
and supernatant was discarded. Next, cell debris and red blood cells were removed
according to the protocol with solutions provided in the kit. Following, cells were
resuspended in a cold buffer containing 0.5% BSA, 0.08 mM EDTA in PBS before the
sorting procedure that was subsequently performed. The cell number was determined
in order to choose the appropriate volume for the binding of the magnetic beads. At
that stage, the cell suspension contained about 1.3 × 107 cells of the cortex and about
6 × 106 cells of the hippocampus of which 40-70% were living. The cells were blocked
by adding FcR Blocking reagent to the cell suspension. After 10 min incubation in
the fridge, Anti-ACSA-2 MicroBeads were added and again incubated for 15 min in
the fridge. Cells with bound MicroBeads were washed (adding buffer, centrifugation
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and resuspension) and were ready for magnetic sorting in LS Columns. The columns
were placed into the magnetic field of the quadro MACS Seperator, rinsed with buffer
and cell suspension was loaded. The flow-through contained the unlabelled cells. The
column was 3 × washed. Subsequently, the cells were collected by removing the column
from the separator and putting buffer onto the column. Firm usage of the plunger
helped to flush the cells in a collection tube. About 3 × 106 astrocytes from the cortex
and 9 × 104 astrocytes from the hippocampus were collected, of which 40-80% were
living. Isolated astrocytes were further used for cell culture in 6-well plate or western
blot similar to the procedure of primary astrocytes.
4.11 Antibody list
Various antibodies were used for immunohistochemial (IHC) stainings or western blot
(WB). For convenience all antibodies are listed here:
Antibody IHC WB Company #
APP CT Y188 1:10000 abcam ab32136
APP NT 1:500 Lichtenthaler’s lab 22c11
TOM20 1:200 1:1000 abcam ab186735
antiGFP 1:500 life technologies A21311
DRP1 1:1000 cell signaling 8570
pDRP1 S616 1:1000 cell signaling 3455
Ezrin 1:500 Sigma E8897
mCherry 1:500 Biolegend clone 8c5.5
βactin 1:10000 Sigma A5316
calnexin 1:10000 Enzo ADI-SPA-860
GFAP 1:500 1:1000 abcam 53554
S100β 1:500 DAKO A21311
Cytochrome C 1:1000 abcam 90529
4.12 Statistics
For statistical evaluation of the data the programme GraphPad Prism 5.04 (GraphPad
Software, Inc., La Jolla, CA USA) was used. Each data set was tested, if the values are
normally distributed (Gaussian distribution). Therefore, the data was checked with
the Shapiro-Wilk normality test. For normally distributed data, parametric tests were
used (unpaired and paired two-tailed Students t-test and two-way ANOVA followed by
Bonferroni post-hoc test), otherwise non-parametric tests were used (Mann Whitney
test). For comparison of the frequency distribution, Kolmogorov-Smirnov test was
applied. P -value > 0.05 was defined as statistically significant.
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